<SEC-DOCUMENT>0001121404-22-000018.txt : 20221028
<SEC-HEADER>0001121404-22-000018.hdr.sgml : 20221028
<ACCEPTANCE-DATETIME>20221028111628
ACCESSION NUMBER:		0001121404-22-000018
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		6
CONFORMED PERIOD OF REPORT:	20220930
FILED AS OF DATE:		20221028
DATE AS OF CHANGE:		20221028

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Sanofi
		CENTRAL INDEX KEY:			0001121404
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				133529324
		STATE OF INCORPORATION:			I0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-31368
		FILM NUMBER:		221339788

	BUSINESS ADDRESS:	
		STREET 1:		54 RUE LA BOETIE
		CITY:			PARIS
		STATE:			I0
		ZIP:			75008
		BUSINESS PHONE:		33153774400

	MAIL ADDRESS:	
		STREET 1:		54 RUE LA BOETIE
		CITY:			PARIS
		STATE:			I0
		ZIP:			75008

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SANOFI-AVENTIS
		DATE OF NAME CHANGE:	20040826

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SANOFI SYNTHELABO SA
		DATE OF NAME CHANGE:	20010104
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>a6kcoverpagepressreleaseq3.htm
<DESCRIPTION>6-K
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="id0f64c7d07f34faa859e101a3b0517d3_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNITED STATES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM&#160;6-K</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REPORT OF FOREIGN PRIVATE ISSUER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO RULE&#160;13a-16&#160;OR&#160;15d-16</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNDER THE SECURITIES EXCHANGE ACT OF 1934</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the month of October 2022</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number&#58;&#160;001-31368</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SANOFI</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Translation of registrant&#8217;s name into English)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">54, rue La Bo&#233;tie, 75008 Paris, FRANCE</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Address of principal executive offices)</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant files or will file annual reports under cover Form&#160;20-F&#160;or Form&#160;40-F.</font></div><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Form 20-F&#160;&#160;&#9746;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Form&#160;40-F&#160;&#160;&#9744;</font></div><div style="margin-top:3pt;text-align:center"><font><br></font></div><div style="margin-top:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is submitting the Form&#160;6-K&#160;in paper as permitted by Regulation&#160;S-T&#160;Rule 101(b)(1)&#58;&#160;&#160;&#9744;</font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is submitting the Form&#160;6-K&#160;in paper as permitted by Regulation&#160;S-T&#160;Rule 101(b)(7)&#58;&#160;&#160;&#9744;</font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule&#160;12g3-2(b)&#160;under the Securities Exchange Act of 1934.</font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Yes&#160;&#160;&#9744;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;No&#160;&#160;&#9746;</font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><font><br></font></div><div style="margin-top:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If &#8220;Yes&#8221; marked, indicate below the file number assigned to the registrant in connection with Rule&#160;12g3-2(b)&#58;&#160;82-&#160;</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2022, Sanofi issued the press release attached hereto as Exhibit 99.1 which is incorporated herein by reference.</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit Index</font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.035%"><tr><td style="width:1.0%"></td><td style="width:20.574%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:77.226%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit No.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Description</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 99.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Press release dated October 28, 2022&#58; Continued strong growth in Q3 with key regulatory milestones achieved</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SIGNATURES</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.163%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.303%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.635%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58; October 28, 2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SANOFI</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#47;s&#47; Alexandra Roger</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alexandra Roger</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Head of Securities Law and Capital Markets</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>pressreleaseq32022english.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i410bda0d322d42a2b8a6ead5105a1298_1"></div><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:right"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Press Release                                                              </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><img alt="image.jpg" src="image.jpg" style="height:45px;margin-bottom:5pt;vertical-align:text-bottom;width:165px"></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font><br></font></div><div style="margin-top:15pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:115%">Continued strong growth in Q3 with key regulatory milestones achieved </font></div><div style="margin-bottom:9pt;padding-left:15.1pt;text-indent:-10.8pt"><font><br></font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Paris, October 28, 2022</font></div><div style="margin-bottom:3pt;margin-top:6pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Q3 2022 sales growth of 9.0% at CER driven by Specialty Care and Vaccines</font></div><div style="margin-top:3pt;padding-left:15.1pt;padding-right:2.15pt;text-align:justify;text-indent:-10.8pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:6.44pt">Specialty Care grew 19.9% driven by Dupixent</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> performance (&#8364;2,314 million, +44.5%) and launch momentum in Rare Disease</font></div><div style="margin-top:3pt;padding-left:15.1pt;padding-right:2.15pt;text-align:justify;text-indent:-10.8pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:6.44pt">Vaccines up 23.5% from strong Flu sales in the quarter, rebound of Travel vaccines and growth of Meningitis and PPH franchises</font></div><div style="margin-top:3pt;padding-left:15.1pt;padding-right:2.15pt;text-align:justify;text-indent:-10.8pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:6.44pt">General Medicines achieved 2.4% core assets growth despite lower Lovenox</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> sales due to decreasing demand from COVID-19</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:15.1pt;padding-right:2.15pt;text-align:justify;text-indent:-10.8pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:6.44pt">CHC up 1.9% with strong growth in Digestive Wellness and Cough &#38; Cold in a normalizing market environment post-COVID-19</font></div><div style="margin-bottom:3pt;margin-top:6pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Q3 2022 business EPS</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.85pt;font-weight:700;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:115%"> up 17.9% at CER driven by higher sales and margin expansion</font></div><div style="margin-top:3pt;padding-left:15.1pt;text-align:justify;text-indent:-10.8pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%;padding-left:6.44pt">BOI margin up 1.9 ppt to 36.0% due to gross margin improvement from efficiency gains, product mix and EUROAPI deconsolidation</font></div><div style="margin-top:3pt;padding-left:15.1pt;text-align:justify;text-indent:-10.8pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%;padding-left:6.44pt">Business EPS</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:112%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%"> of &#8364;2.88, up 32.1% on a reported basis and 17.9% at CER</font></div><div style="margin-top:3pt;padding-left:15.1pt;text-align:justify;text-indent:-10.8pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%;padding-left:6.44pt">IFRS EPS of &#8364;1.66, down 9.8 %, reflecting a &#8364;1,586 billion impairment charge related to SAR444245</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:15.1pt;text-indent:-10.8pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Progress on Corporate Social Responsibility strategy</font></div><div style="margin-top:3pt;padding-left:15.1pt;text-align:justify;text-indent:-10.8pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%;padding-left:6.44pt">Access to Medicine Foundation recognized Sanofi Global Health Unit&#8217;s work to improve insulin access in low-middle income countries</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:15.1pt;text-align:justify;text-indent:-10.8pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Key R&#38;D milestones and regulatory achievements </font></div><div style="margin-top:3pt;padding-left:15.1pt;padding-right:2.15pt;text-align:justify;text-indent:-10.8pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:6.44pt">Dupixent</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> approved in the U.S. as the first and only treatment for adults with prurigo nodularis</font></div><div style="margin-top:3pt;padding-left:15.1pt;padding-right:2.15pt;text-align:justify;text-indent:-10.8pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:6.44pt">FDA granted priority review for Altuviiio&#8482;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"> (</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">efanesoctocog alfa) for the treatment of hemophilia A</font></div><div style="margin-top:3pt;padding-left:15.1pt;padding-right:2.15pt;text-align:justify;text-indent:-10.8pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:6.44pt">FDA approved Xenpozyme</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">TM </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">for the treatment of acid sphingomyelinase deficiency (ASMD) in adult and pediatric patients</font></div><div style="margin-top:3pt;padding-left:15.1pt;padding-right:2.15pt;text-align:justify;text-indent:-10.8pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:6.44pt">CHMP recommended approval of Beyfortus</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> (nirsevimab) for prevention of RSV disease in infants </font></div><div style="margin-top:3pt;padding-left:15.1pt;padding-right:2.15pt;text-align:justify;text-indent:-10.8pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:6.44pt">CHMP recommended approval of Enjaymo&#8482; in adult patients with cold agglutinin disease (CAD)</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:15.1pt;text-align:justify;text-indent:-10.8pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Full-year 2022 business EPS guidance revise upward</font></div><div style="margin-bottom:3pt;padding-left:15.1pt;padding-right:2.15pt;text-align:justify;text-indent:-10.8pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:6.44pt">Sanofi now expects 2022 business EPS</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> to grow approximately 16%</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> at CER, barring unforeseen major adverse events. Applying average October 2022 exchange rates, the positive currency impact on 2022 business EPS is estimated between +9.5% to +10.5%</font></div><div style="margin-bottom:3pt;margin-top:6pt"><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Sanofi Chief Executive Officer, Paul Hudson, commented&#58;</font></div><div style="margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">&#8220;Our strong results for the third quarter demonstrate that Sanofi is on the right path, with a remarkable performance of 20% growth in both Specialty Care and Vaccines, leading us to again raise our business EPS guidance for the full-year. Our commitment to breakthrough science is bearing fruit. Three of our priority first or best-in-class medicines reached important regulatory milestones. Beyfortus</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"> was recommended by EMA&#8217;s CHMP for prevention of RSV disease in all infants while Altuviiio&#8482; was granted priority review by the US FDA for people with hemophilia A. Dupixent</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"> keeps breaking new ground with a recent US FDA approval making it the first and only treatment indicated for prurigo nodularis, the second indication in dermatology, and fifth overall for Dupixent in the US. Social impact continues to be at the center of our company&#8217;s agenda, as illustrated by the introduction of our first two carbon offsetting programs. Looking ahead, we are well positioned to achieve our BOI margin target of 30% in 2022 and to stay focused on our ambition to transform the practice of medicines for patients around the world.&#8221;</font></div><div style="margin-bottom:6pt;text-align:justify"><font><br></font></div><div id="i410bda0d322d42a2b8a6ead5105a1298_4"></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.558%"><tr><td style="width:1.0%"></td><td style="width:24.005%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.385%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:0 1pt"></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q3 2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change <br>at CER</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9M 2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change <br>at CER</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">IFRS net sales reported</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8364;12,482m</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+19.7%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+9.0%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8364;32,272m</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+16.2%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+8.6%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">IFRS net income reported</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8364;2,076m</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-10.1%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">_</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8364;5,260m</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+3.7%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">IFRS EPS reported</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8364;1.66</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-9.8%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">_</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8364;4.20</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+3.7%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;</font></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #525ca3;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-right:-4.05pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Free cash flow</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</font></div></td><td colspan="3" style="background-color:#f4f2f6;border-top:0.5pt solid #525ca3;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8364;2,695m</font></td><td colspan="3" style="border-top:0.5pt solid #525ca3;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+22.4%</font></td><td colspan="3" style="border-top:0.5pt solid #525ca3;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">_</font></td><td colspan="3" style="background-color:#f4f2f6;border-top:0.5pt solid #525ca3;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8364;5,937m</font></td><td colspan="3" style="border-top:0.5pt solid #525ca3;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+6.9%</font></td><td colspan="3" style="border-top:0.5pt solid #525ca3;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8212;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Business operating income</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8364;4,498m</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+26.5%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+13.0%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8364;10,316m</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+22.0%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+12.8%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-right:-4.05pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Business net income</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8364;3,606m</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+31.8%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+17.7%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8364;8,200m</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+26.5%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+16.9%</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #525ca3;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-right:-4.05pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Business EPS</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8364;2.88</font></td><td colspan="3" style="border-bottom:0.5pt solid #525ca3;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+32.1%</font></td><td colspan="3" style="border-bottom:0.5pt solid #525ca3;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+17.9%</font></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8364;6.55</font></td><td colspan="3" style="border-bottom:0.5pt solid #525ca3;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+26.4%</font></td><td colspan="3" style="border-bottom:0.5pt solid #525ca3;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+17.0%</font></td></tr></table></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:115%">Changes in net sales are expressed at constant exchange rates (CER) unless otherwise indicated (definition in Appendix 7). (1) In order to facilitate an understanding of operational performance, Sanofi comments on the business net income statement. Business net income is a non-GAAP financial measure (definition in Appendix 7). The consolidated income statement for Q3 2022 is provided in Appendix 3 and a reconciliation of reported IFRS net income to business net income is set forth in Appendix 4&#59; (2) 2021 business EPS was &#8364;6.56&#59; (3) Free cash flow is a non-GAAP financial measure (definition in Appendix 7).</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  1                   </font></div></div></div><div id="i410bda0d322d42a2b8a6ead5105a1298_7"></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:115%">2022 third-quarter and nine-months Sanofi sales</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">----------------------------</font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Unless otherwise indicated, all percentage changes in sales in this press release are stated at CER</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">---------------------</font></div><div id="i410bda0d322d42a2b8a6ead5105a1298_10"></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the third quarter of 2022, Sanofi sales were &#8364;12,482 million, up 19.7% on a reported basis. Exchange rate movements had a positive effect of 10.7 percentage points, mainly due to the U.S. dollar. At CER, company sales were up 9.0%.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first nine months of 2022, Sanofi sales reached &#8364;32,272 million, up 16.2% on a reported basis. Exchange rate movements had a positive effect of 7.6 percentage points. At CER, company sales were up 8.6%.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#23004c;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Global Business Units</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Third-quarter 2022 net sales by Global Business Unit (variation at CER&#59; &#8364; million&#59; % of total sales)</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><img alt="chart-c3aee8ddf68f4083a75.jpg" src="chart-c3aee8ddf68f4083a75.jpg" style="height:270px;margin-bottom:5pt;vertical-align:text-bottom;width:654px"></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Third-quarter 2022 net sales by geographic region (variation at CER&#59; &#8364; million&#59; % of total sales)</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><img alt="chart-6387a406886e4caa9ed.jpg" src="chart-6387a406886e4caa9ed.jpg" style="height:275px;margin-bottom:5pt;vertical-align:text-bottom;width:650px"></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Third-quarter 2022 operating income</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Third-quarter </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">business operating income</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (BOI) increased 26.5% to &#8364;4,498 million. At CER, BOI increased 13.0%. The ratio of BOI to net sales increased 1.9 percentage point to 36.0% (35.3% at CER)</font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. In the first nine months, </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">BOI increased 22.0% to &#8364;10,316 million. At CER, BOI increased 12.8%. T</font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">he ratio of business operating income to net sales increased 1.5 percentage point to 32.0% (31.6% at CER). </font></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:4.55pt;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">See Appendix 7 for definitions of financial indicators.</font></div><div style="margin-top:6pt;text-align:justify"><font><br></font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  2                   </font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font><br></font></div><div id="i410bda0d322d42a2b8a6ead5105a1298_16"></div><div style="margin-bottom:6pt"><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:115%">Pharmaceuticals</font></div><div id="i410bda0d322d42a2b8a6ead5105a1298_19"></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Third-quarter Pharmaceutical sales increased 5.1% to &#8364;7,896 million, mainly driven by the Specialty Care portfolio (up 19.9%) with continued strong performance of Dupixent</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> while sales in General Medicines decreased 8.5%. In the first nine months of 2022, Pharmaceuticals sales increased 6.8% to &#8364;22,895 million reflecting the strong performance of Specialty Care and General Medicines core assets.</font></div><div id="i410bda0d322d42a2b8a6ead5105a1298_25"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><font style="color:#23004c;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Specialty Care</font></div><div id="i410bda0d322d42a2b8a6ead5105a1298_28"></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dupixent</font></div><div style="margin-bottom:1pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.698%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.569%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net sales (&#8364; million)</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q3 2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change <br>at CER</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9M 2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change <br>at CER</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:133%">Total Dupixent</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.85pt;font-weight:700;line-height:133%;position:relative;top:-3.15pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,314</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">+44.5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5,891</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">+44.5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">%</font></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the third quarter, </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Dupixent</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (collaboration with Regeneron) sales increased 44.5% to &#8364;2,314 million. In the U.S., Dupixent</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7.8pt;font-weight:400;line-height:115%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales of &#8364;1,803 million (up 45.1%) were driven by continued strong demand in the approved indications, atopic dermatitis (AD), asthma, chronic rhinosinusitis with nasal polyposis (CRSwNP) and the strong launches of AD in children as young as 6 months as well as eosinophilic esophagitis approved in May. Dupixent</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7.8pt;font-weight:400;line-height:115%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> total prescriptions (TRx) increased 38% (y</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">ear-over-year</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">) and new-to-brand prescriptions (NBRx) grew 49%. In Europe, third-quarter Dupixent</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7.8pt;font-weight:400;line-height:115%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales grew 38.7% to &#8364;241 million reflecting continued growth in AD, asthma and CRSwNP. In the Rest of the World region, third-quarter sales reached &#8364;270 million, up 46.6%, driven mainly by sales in Japan and China. First-nine months Dupixent</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales reached &#8364;5,891 million, up 44.5%. </font></div><div id="i410bda0d322d42a2b8a6ead5105a1298_31"></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Neurology and Immunology</font></div><div style="margin-bottom:1pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.698%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.569%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net sales (&#8364; million)</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q3 2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change <br>&#160;at CER</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9M 2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change <br>&#160;at CER</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:133%">Aubagio</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:133%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">521&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-3.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,538&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-4.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:133%">Lemtrada</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:133%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-20.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-6.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:133%">Kevzara</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:133%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">88&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-2.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">260&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+25.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Neurology and Immunology</font></div></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">627</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">-4.1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,861</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">-0.9</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">%</font></td></tr></table></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the third quarter and the first nine months, </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Neurology and Immunology </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">sales decreased 4.1% (to &#8364;627 million) and 0.9% respectively, mainly due to lower Aubagio</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales. </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Aubagio</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">sales decreased 3.7% in the third quarter to &#8364;521 million due to lower sales in the U.S. as a result of both competitive pressure and price an</font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">d in the Rest of the World region.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Third-quarter </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Kevzara</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (collaboration with Regeneron) sales decreased 2.4% to &#8364;88 million due to a high base in the third quarter of 2021 which benefitted from a temporary increased global demand for IL-6 receptor blockers.</font></div><div id="i410bda0d322d42a2b8a6ead5105a1298_34"></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Rare Disease</font></div><div style="margin-bottom:1pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.698%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.569%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net sales (&#8364; million)</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q3 2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change <br>at CER</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9M 2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change <br>at CER</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:133%">Myozyme</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:133%;position:relative;top:-2.8pt;vertical-align:baseline">&#174; </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:133%">&#47; Lumizyme</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:133%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">255&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-10.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">742&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-5.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:133%">Fabrazyme</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:133%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">240&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+5.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">698&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+5.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:133%">Cerezyme</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:133%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">181&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+8.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">548&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+6.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:133%">Cerdelga</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:133%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">78&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+10.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">217&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+8.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:133%">Aldurazyme</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:133%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+15.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">202&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+8.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nexviazyme</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#47;Nexviadyme</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">58&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:36pt;text-align:right;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</font></div></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">131</font></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:36pt;text-align:right;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Others Rare Disease</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-17.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">57&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-14.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Rare Disease</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">900</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">+7.7</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,595</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">+7.1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">%</font></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the third quarter, </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Rare Disease</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales increased 7.7% to &#8364;900 million driven by growth of Pompe franchise as well as Gaucher franchise in the Rest of the World region which benefitted from favorable purchasing patterns. First-nine months sales of Rare Disease increased 7.1% reflecting growth across all three geographic regions and across all core franchises.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Third-quarter sales of the </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Pompe franchise</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> increased 8.2% to &#8364;313 million driven by the ramp up of Nexviazyme</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;&#47;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Nexviadyme</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">in the U.S., Europe and Japan. Sales of </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Nexviazyme</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:700;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">&#47;Nexviadyme</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> were &#8364;58 million in the third quarter (of which &#8364;46 million in the U.S.). </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Myozyme</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:700;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">&#47;Lumizyme</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales </font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  3                   </font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">decreased 10.2% to &#8364;255 million mainly reflecting the conversion to Nexviazyme</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:700;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in the eligible Pompe population (late-onset disease).</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Sales of the </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Gaucher</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> franchise increased 9.4% (to &#8364;259 million) in the third quarter. </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Cerezyme</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales were up 8.8% to &#8364;181 million, driven by the Rest of the World region, reflecting favorable purchasing patterns and sustained new patient accruals. In parallel, </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Cerdelga</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales were up 10.9% driven by switches and new patient accruals.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Third-quarter </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Fabrazyme</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales increased 5.7% to &#8364;240 million reflecting growth in all three geographic regions. </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Xenpozyme</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:700;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">TM</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (olipudase alfa) was launched in Japan in June as the first and only enzyme replacement therapy for the treatment of non-Central Nervous System (CNS) manifestations of Acid Sphingomyelinase. Third-quarter sales were &#8364;2 million.</font></div><div id="i410bda0d322d42a2b8a6ead5105a1298_37"></div><div style="margin-bottom:3pt;margin-top:6pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Oncology </font></div><div style="margin-bottom:1pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.698%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.569%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net sales (&#8364; million)</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q3 2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change <br>at CER</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9M 2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change <br>at CER</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Jevtana</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-13.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">304&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-18.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Sarclisa</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">79&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+54.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">208&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+62.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Fasturtec</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+10.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">130&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+9.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Libtayo</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">88&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-9.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Oncology</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">224</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">-8.4</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">731</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">+2.1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">%</font></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Third-quarter </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Oncology</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales decreased 8.4% (to &#8364;224 million) reflecting the end of consolidation of Libatyo</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales from the beginning of July. Excluding Libtayo</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, Oncology sales were up 8.4% driven by strong growth of Sarclisa</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">which largely offset the impact of Jevtana</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> generic competition in Europe. First-nine months, </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Oncology</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales increased 2.1% and 4.0% when excluding Libtayo</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">sales in both years. </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Sanofi stopped consolidating Libtayo</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> non-U.S. sales from the third quarter of 2022 following the restructuring of its immuno-oncology collaboration with Regeneron Pharmaceuticals, Inc. Under the amended and restated license and collaboration agreement, Regeneron has obtained worldwide exclusive license rights to Libtayo</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. Prior, the companies had split equally Libtayo</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8217;s worldwide operating profits and co-commercialized Libtayo</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in the U.S., with Sanofi solely responsible for commercialization in the rest of the world.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Third-quarter </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Sarclisa</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales were &#8364;79 million, up 54.2% primarily driven by performance in the U.S. (&#8364;37 million, up 72.2%), Europe and Japan. </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Third-quarter </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Jevtana</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales decreased 13.3% to &#8364;101 million following the entry of generic competition in Europe at the end of March 2021. In the U.S., Jevtana</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> is currently covered by four Orange Book listed patents US 7,241,907, US 8,927,592, US 10,583,110 and US 10,716,777. Sanofi filed patent infringement suits under Hatch-Waxman against generic filers asserting the &#8216;110 patent, the &#8216;777 patent and the '592 patent in the US District Court for the District of Delaware. Sanofi has reached settlement agreements with some of the defendants and the suit against the remaining defendants is ongoing. In August 2022, the district court dismissed Sanofi&#8217;s infringement claim related to the &#8216;592 patent. A 3-day trial related to the &#8216;110 patent and the &#8216;777 patent has been scheduled in January 2023 and the remaining defendants have agreed not to launch any generic cabazitaxel product until the earlier of a district court decision in favor of the defendants or four months after the completion of the post-trial briefing.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font><br></font></div><div id="i410bda0d322d42a2b8a6ead5105a1298_40"></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Rare Blood Disorders </font></div><div style="margin-bottom:1pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.977%"><tr><td style="width:1.0%"></td><td style="width:19.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.873%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net sales (&#8364; million)</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q3 2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change <br>at CER</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9M 2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change <br>at CER</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:133%">Eloctate</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:133%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">151&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-7.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">442&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-4.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:133%">Alprolix</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:133%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">126&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+8.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">363&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+9.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:133%">Cablivi</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:133%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+14.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">149&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+11.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Enjaymo</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">TM</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:36pt;text-align:right;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:36pt;text-align:right;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</font></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Rare Blood Disorders</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">336</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">+3.5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">965</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">+3.7</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">%</font></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the third quarter, </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Rare Blood Disorders</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> franchise sales increased 3.5% (&#8364;336 million), mainly reflecting Alprolix</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and Cablivi</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">growth partially offset by lower Eloctate</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales. First-nine months franchise sales were up 3.7% driven by Alprolix</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">and Cablivi</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  4                   </font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Eloctate</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales were &#8364;151 million in the third quarter, down 7.6% reflecting lower sales in the U.S. due to competitive pressure and lower sales in the rest of the world region. </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Third-quarter </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Alprolix</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales were up 8.9% to &#8364;126 million driven by the U.S. </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Cablivi</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales increased by 14.3% to &#8364;52 million in the third quarter supported by growth in the U.S. and in Europe. </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Third-quarter sales of </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Enjaymo</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8482;, the first approved treatment for patients with cold agglutinin disease were &#8364;7 million (U.S. approval in February. The roll-out in Japan started in September). </font></div><div id="i410bda0d322d42a2b8a6ead5105a1298_43"></div><div style="margin-top:12pt"><font style="color:#23004c;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:700;line-height:120%">General Medicines</font><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Third-quarter General Medicines sales decreased 8.5% to &#8364;3,495 million. Adjusted from portfolio streamlining and excluding EUROAPI</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> third party sales (in the third quarter of 2022 and 2021), sales decreased 4.1%. Third-quarter Industrial sales were &#8364;127 million, down </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">43.3%</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and reflected deconsolidation of EUROAPI third party sales from May 10.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">First-nine months sales of General Medicines decreased 4.4%. Adjusted from portfolio streamlining and excluding EUROAPI third party sales (in the first nine months of 2022 and 2021), sales decreased 1.6%. In the first nine months, core assets</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales accounted for 44.1% of General Medicines sales compared with 40.2% for the same period of 2021.</font></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Core assets</font></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.558%"><tr><td style="width:1.0%"></td><td style="width:31.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.732%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net sales (&#8364; million)</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q3 2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change <br>at CER</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9M 2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change <br>at CER</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Lovenox</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;*</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">307&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-23.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,021&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-14.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Toujeo</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">304&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+17.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">845&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+8.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Plavix</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">230&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-1.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">738&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-0.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Praluent</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">83&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+33.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">280&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+63.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Thymoglobulin</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">118&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+15.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">328&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+13.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Multaq</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+10.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">279&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+8.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mozobil</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">68&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+1.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">192&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+4.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Soliqua</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">54&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-5.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">160&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+4.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Rezurock</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">60&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:36pt;text-align:right;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">144&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:36pt;text-align:right;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#8211;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Others</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">261&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-2.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">804&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-1.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total core assets</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,586</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">+2.4</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4,791</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">+4.3</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">%</font></td></tr></table></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">*</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">Excluding Auto generics</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the third quarter, </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">core assets</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:700;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales increased 2.4% to &#8364;1,586 million, driven by double-digit growth of Toujeo</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, Praluent</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, Thymoglobulin</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and Multaq</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> as well as the strong performance of Rezurock</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, partially offset by lower sales of Lovenox</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. In the first nine months, </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">core assets</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales increased 4.3% to &#8364;4,791 million sustained by growth of Praluent</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">,</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Thymoglobulin</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;,</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Toujeo</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and Multaq</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> as well as the contribution of Rezurock</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Third-quarter </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Lovenox</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">sales decreased 23.0% to &#8364;307 million, reflecting a high comparative base in 2021 due to COVID-19 related demand, leading to a decrease</font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of the Low Weight Molecular Heparins market. At the same time competition of biosimilars is increasing. </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Third-quarter </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Toujeo</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales increased 17.2% to &#8364;304 million, reflecting growth in Europe and in the Rest of the World region where Toujeo</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> benefitted from a strong demand in China and favorable phasing.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Plavix</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">sales were down 1.4% in the third quarter at &#8364;230 million, reflecting consistent volume growth in China (sales were up 7.8% to &#8364;106 million). This was offset by lower sales in Europe and the Rest of the World region, including Japan where the product was impacted by a mandatory price cut at the beginning of April.</font></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Praluent</font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> third-quarter sales were &#8364;83 million, up 33.9%,</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">driven by performance in Europe and an accelerated ramp-up in China due to the inclusion in the NDRL effective January 2022.</font></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Multaq</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> third-quarter sales grew 10.1% to &#8364;101 million, reflecting growth in the U.S.</font></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Sales of </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Rezurock</font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> were &#8364;60 million in the third quarter. Since launch more than 1300 patients have been treated with Rezurock</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (more than 30% of current addressable patient population) with excellent persistency rates. </font></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> EUROAPI third party sales were deconsolidated from May 10</font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:4.55pt;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">Sanofi has prioritized core assets in its General Medicines portfolio with differentiated and&#47;or established profiles that have significant opportunity for growth in key markets. Core assets include Toujeo, Soliqua, Praluent, Multaq, Lovenox, Plavix and others for total sales of &#8364;5.768 million in 2021</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  5                   </font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Non-core assets </font></div><div style="margin-bottom:1pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.558%"><tr><td style="width:1.0%"></td><td style="width:31.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.732%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net sales (&#8364; million)</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q3 2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change <br>at CER</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9M 2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change <br>at CER</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Lantus</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;*</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">559&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-17.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,830&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-10.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Aprovel</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#47;Avapro</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">129&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+11.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">374&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+14.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other non-core assets</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,094&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-12.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,414&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-9.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total non-core assets</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,782</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">-12.8</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5,618</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">-8.5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">%</font></td></tr></table></div><div style="margin-bottom:6pt;margin-top:1pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the third quarter, </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">non-core assets sales </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">decreased 12.8% to &#8364;1,782 million reflecting divestments (-1.7 ppt), and VBP impact in China on Lantus</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> as well as on Eloxatin</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and Taxotere</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales. In the first nine months, </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">non-core assets sales </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">decreased 8.5% and 6.9% (-1.6 ppt) excluding divestments.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Lantus</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales were &#8364;559 million, down 17.7% in the third quarter. In the U.S., sales decreased 7.0%, impacted by formulary losses as well as by erosion of the basal insulin market. In Rest of the World region, sales were down 26.5% reflecting the insulin VBP in China starting in May this year. </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In China, Sanofi participated in the VBP tender for basal insulin analogues in November and was among the bidding winners in Group A with Toujeo</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">and Lantus</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In 2022, Sanofi expects its glargine sales to decrease not more than 30% in </font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">China, benefiting from higher volumes at significantly lower prices. In China, third-quarter</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and first nine months Toujeo</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#47;Lantus</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales were &#8364;102 million (down 31.6%) and &#8364;396 million (down 13.7%), respectively, mainly reflecting lower Lantus</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Third-quarter </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Aprovel</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:700;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">&#47;Avapro</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> sales were up 11.2% to &#8364;129 millio</font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">n driven by the Rest of the World </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">region winning back market share following supply constraints in the previous year.</font></div><div id="i410bda0d322d42a2b8a6ead5105a1298_49"></div><div style="margin-top:6pt;text-align:justify"><font style="color:#23004c;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Pharmaceuticals business operating income</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the third quarter, </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">business operating income</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (BOI) of Pharmaceuticals increased 20.3% to &#8364;2,896 million (up 8.4% at CER). The ratio of BOI to net sales increased by 1.6 percentage point to 36.7% (36.2% at CER), reflecting an improvement of the gross margin ratio, higher capital gains related to portfolio streamlining and the positive impact of the amended immuno-oncology and antibody collaborations, despite continued growth of R&#38;D expenses. </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">First-nine months business operating income of Pharmaceuticals increased 16.9% to &#8364;8,553 million (up 9.2% at CER). The ratio of BOI to net sales increased by 0.9 percentage point to 37.4% (37.3% at CER). </font></div><div id="i410bda0d322d42a2b8a6ead5105a1298_55"></div><div style="margin-bottom:3pt"><font><br></font></div><div style="margin-bottom:3pt"><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:115%">Vaccines</font><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:16pt;font-style:italic;font-weight:700;line-height:115%"> </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.698%"><tr><td style="width:1.0%"></td><td style="width:33.353%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.286%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.286%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.286%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.289%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net sales (&#8364; million)</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q3 2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change <br>at CER</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9M 2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change <br>at CER</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:174%">Influenza vaccines</font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:174%">(incl. Fluzone</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:174%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:174%"> HD&#47; Efluelda</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:174%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:174%">, Fluzone</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:174%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:174%">, Flublok</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:174%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:174%">, Vaxigrip</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:174%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:174%">)</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,994&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+32.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,175&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+26.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:174%">Polio&#47;Pertussis&#47;Hib vaccines </font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:174%">(incl. Hexaxim</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:174%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:174%"> &#47; Hexyon</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:174%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:174%">, Pentacel</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:174%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:174%">, Pentaxim</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:174%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-style:italic;font-weight:700;line-height:174%;position:relative;top:-2.8pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:174%">and Imovax</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:174%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:174%">)</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">640&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+9.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,842&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+9.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:174%">Meningitis vaccines </font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:174%">(incl. Menactra</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:174%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;, </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:174%">MenQuadfi</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:174%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:174%">)</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">328&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+11.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">593&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-6.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:174%">Booster vaccines </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:174%">(incl. Adacel</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:174%;position:relative;top:-3.5pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:174%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:174%">)</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">178&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+1.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">439&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+11.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Travel and endemic vaccines</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">146&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+64.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">389&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+70.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other vaccines</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-7.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+8.1%</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Vaccines</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,315</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">+23.5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5,513</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">+16.5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">%</font></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Third-quarter </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Vaccines</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales increased 23.5% (to &#8364;3,315 million) mainly driven by higher influenza vaccines sales. First-nine months Vaccines sales were up 16.5%, reflecting influenza and Polio&#47;Pertussis&#47;Hib vaccines sales growth and progressive recovery of Travel and Booster vaccines.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Influenza vaccines</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales increased 32.4% to &#8364;1,994 million in the third quarter, driven by manufacturing excellence and in-market execution, leading to earlier influenza vaccines shipments than last year as well as a favorable product mix driven by Fluzone</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:700;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> HD in the U.S. and Efluelda</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:700;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in Europe. Third-quarter influenza sales represented approximately 70% of northern hemisphere sales expected in the second half of 2022. </font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  6                   </font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the third quarter, </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Polio&#47;Pertussis&#47;Hib</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (PPH) vaccines sales increased 9.1% to &#8364;640 million sustained by the Rest of the World region benefitting from favorable purchasing patterns in public markets. Vaxelis</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> market share continues to grow in the U.S. As a reminder, Vaxelis</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> in-market sales are not consolidated and the profits are shared equally between Sanofi and Merck. </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Third-quarter </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Meningitis</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales increased 11.9% to &#8364;328 million, reflecting favorable CDC inventory fluctuation in the U.S. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Booster</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> vaccines sales increased 1.3% in the third quarter to &#8364;178 million, still below pre-pandemic levels.  </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Third-quarter </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Travel and endemic vaccines</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales increased 64.6% to &#8364;146 million, reflecting growth across all geographies in a post pandemic environment.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font><br></font></div><div id="i410bda0d322d42a2b8a6ead5105a1298_58"></div><div style="text-align:justify"><font style="color:#23004c;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Vaccines business operating income</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the third quarter, </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">business operating income</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (BOI) increased 46.2% (up 29.7% at CER) to &#8364;1,987 million compared to the same period of last year, reflecting strong sales growth despite higher R&#38;D expenses related to Translate Bio and the mRNA center of excellence. BOI to net sales ratio was 59.9% (58.9% at CER) versus 56.1% for the same period of 2021. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In the first nine months of 2022, BOI of Vaccines increased 31.3% (up 17.6% at CER) to &#8364;2,569 million reflecting strong sales growth, gross margin improvement and moderate SG&#38;A evolution which largely offset the payment from Daiichi Sankyo recorded in the first quarter of 2021, as well as higher R&#38;D costs in 2022. The ratio of BOI to net sales was 46.6% (45.3% at CER) versus 44.9% in the first nine months of 2021.</font></div><div style="margin-top:6pt;text-align:justify"><font><br></font></div><div id="i410bda0d322d42a2b8a6ead5105a1298_64"></div><div><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:115%">Consumer Healthcare</font></div><div style="margin-bottom:1pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.977%"><tr><td style="width:1.0%"></td><td style="width:22.363%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.035%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net sales (&#8364; million)</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q3 2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">Change </font></div><div style="text-align:right"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">at CER</font></div></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9M 2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">Change </font></div><div style="text-align:right"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">at CER</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Allergy</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">160&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-0.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">578&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+9.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cough &#38; Cold </font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">127&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+30.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">346&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+66.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pain Care</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">292&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-3.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">910&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+7.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Digestive Wellness</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">351&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+14.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,012&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+12.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Physical and Mental Wellness</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">142&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-5.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">438&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+3.7%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Personal Care</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">150&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-2.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">429&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+0.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-Core &#47; Others</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-35.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">151&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-27.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Consumer Healthcare</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,271</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">+1.9</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,864</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">+9.2</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">%</font></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the third quarter, </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Consumer Healthcare</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (CHC) sales increased 1.9% to &#8364;1,271 million driven by growth in Europe and the Rest of the World region and compared with the high basis in the third quarter 2021 which benefitted from COVID-19 related demand. This global performance includes a positive price effect of 5.4 percentage points (ppt). The divestments of non-core products had a negative impact of 1.6 ppt in the third quarter mainly impacted the Non-core&#47;others category. First-nine months CHC sales increased 9.2% supported by double-digit growth in Europe and the Rest of the World region. In the first nine month, the divestments of non-core products had a negative impact of 1.2 ppt. </font></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> U.S.</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, third-quarter CHC sales decreased 5.9% to &#8364;319 million due to Q3 2021 high basis related to post Covid sales rebound, as well as a broad market slow down initiated in August.</font></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Europe</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, third-quarter CHC sales increased 5.1% to &#8364;349 million mainly reflecting longer lasting Cough &#38; Cold season and also divestments. </font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Rest of World</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, third-quarter CHC sales increased 4.1% to &#8364;603 million, supported by strong growth of </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Digestive Wellness driven by Enterogermina offsetting </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">divestments. </font></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><font><br></font></div><div id="i410bda0d322d42a2b8a6ead5105a1298_67"></div><div style="text-align:justify"><font style="color:#23004c;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:700;line-height:115%">CHC business operating income</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In the third quarter, </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">business operating income</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (BOI) of CHC decreased 11.6% (down 19.0% at CER) to &#8364;410 million, reflecting higher R&#38;D expenses as well as capital gains related to divestments of non-strategic assets recorded in Q3 2021. The ratio of BOI to net sales decreased 7.9 percentage points to 32.3% (31.9% at CER) versus the prior year. In the first nine months</font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">BOI of CHC increased 19.6% (up 13.4% at CER) to &#8364;1,429 million driven by the strong sales growth and higher capital gains related to divestments of non-strategic assets. The ratio of BOI to net sales increased 1.4 percentage point to 37.0% (37.0% at CER).</font></div><div id="i410bda0d322d42a2b8a6ead5105a1298_73"></div><div style="margin-top:6pt"><font><br></font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  7                   </font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="margin-top:6pt"><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:115%">Company sales by geographic region</font></div><div style="margin-bottom:1pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.838%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Sanofi sales (&#8364; million)</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q3 2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change <br>at CER</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9M 2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change <br>at CER</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6,042</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">+15.0</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">13,604</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">+13.5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Europe</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,596</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">+4.6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">7,363</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">+5.6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of the World</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,844</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">+4.5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">11,305</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">+5.6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">of which China</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">846&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-1.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">2,545&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+7.2%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">of which Japan</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">371&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-5.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">1,207&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+0.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">of which Brazil</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">220&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-4.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">723&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-3.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:133%">of which Russia</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">161&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">-18.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">502&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">+1.1%</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Sanofi sales</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12,482</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">+9.0</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">32,272</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">+8.6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:0.5pt solid #525ca3;border-top:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">%</font></td></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Third-quarter the </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">U.S.</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> increased 15.0% (to &#8364;6,042 million), supported by the strong performance of specialty care driven by Dupixent</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, Flu vaccines and core assets from General Medicines.</font></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Europe</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> third-quarter sales increased 4.6% (to &#8364;2,596 million) mainly driven by Dupixent</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> performance as well as strong Flu Vaccines growth. </font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In the </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Rest of World region</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:700;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">,</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">third-quarter sales increased 4.5% (to &#8364;3,844 million), reflecting the performance of Specialty care driven by Dupixent</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and growth of Flu Vaccines. Sales in </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">China</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> decreased 1.8% to &#8364;846 million, reflecting VBP impact on Lantus</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> as well as on Eloxatin</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and Taxotere</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> sales which offset the growth of Dupixent</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Praluent</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and Plavix</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. In</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> Japan,</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> third-quarter sales decreased 5.9% to &#8364;371 million, reflecting lower sales of CHC, Vaccines, non-core assets of General Medicine and Plavix</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, despite strong growth of Dupixent</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Sarclisa</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. In </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Russia</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, third-quarter sales decreased 18.7% to 161 million. In March, Sanofi has stopped any new spending not related to the supply of its essential and life-changing medicines and vaccines in Russia. This includes all advertising and promotional spending. Third-quarter sales in Mexico, South Africa and Australia delivered strong growth.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  8                   </font></div></div></div><div id="i410bda0d322d42a2b8a6ead5105a1298_76"></div><hr style="page-break-after:always"><div style="min-height:49.5pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:115%">R&#38;D update at the end of the third quarter 2022</font></div><div><font><br></font></div><div><font style="color:#23004c;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Regulatory update</font><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:115%"> </font></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.55pt">The U.S. Food and Drug Administration (FDA) approved </font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Dupixent</font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (dupilumab) for the treatment of adult patients with </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">prurigo nodularis</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (PN), following priority review. With this approval, Dupixent is now the first and only medicine specifically indicated to treat this chronic, debilitating skin disease with underlying type 2 inflammation. About 75,000 adults in the U.S. are living with prurigo nodularis and its impact on quality of life is one of the highest among inflammatory skin diseases.  </font></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.55pt">The FDA accepted for priority review the Biologics License Application (BLA) for Altuviiio</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">TM</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">efanesoctocog alfa</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, an investigational factor VIII replacement therapy for the treatment of </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">hemophilia A</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, a rare and life-threatening bleeding disorder. The target action date for the FDA decision is February 28, 2023. </font></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.55pt">The FDA approved </font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Xenpozyme</font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">TM</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(olipudase alfa-rpcp) for the treatment of non-central nervous system (non-CNS) manifestations of </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">acid sphingomyelinase deficiency</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (ASMD) in adult and pediatric patients. Xenpozyme is the first therapy indicated specifically for the treatment of ASMD and is currently the only approved treatment for this disease. As a result of the FDA approval, the FDA awarded a Rare Pediatric Disease Priority Review Voucher to Sanofi.</font></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:12.55pt">The European Medicines Agency&#8217;s Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for </font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Beyfortus</font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (nirsevimab) for the prevention of </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">respiratory syncytial virus</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (RSV) lower respiratory tract disease in newborns and infants during their first RSV season. If approved, Beyfortus would be the first and only single-dose passive immunization for the broad infant population, including those born healthy, at term or preterm, or with specific health conditions.</font></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:12.55pt">The CHMP adopted a positive opinion for </font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Enjaymo&#8482;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (sutimlimab), recommending that the C1s protein inhibitor be approved in the European Union for treatment of hemolytic anemia in adult patients with </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">cold agglutinin disease</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (CAD), a rare, serious, and chronic autoimmune hemolytic anemia. Additionally, </font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Enjaymo&#8482;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> efficacy sBLA was granted priority review by the FDA, based on the CADENZA trial, with the aim to broaden the indication.</font></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:12.55pt">The Japanese Ministry of Health, Labor and Welfare (MHLW) approved </font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Cablivi</font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> for the treatment of </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">acquired thrombotic thrombocytopenic purpura</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (aTTP). </font></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#23004c;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Portfolio update</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:36pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Phase 3&#58;</font></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.55pt">Positive data from the Phase 3 ATLAS-PPX study demonstrated 80 mg once-monthly </font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">fitusiran</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> prophylaxis significantly reduced bleeding episodes by 61% compared to prior factor or bypassing agent (BPA) prophylaxis in adults and adolescents with severe </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">hemophilia A or B</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, with a median annualized bleeding rate (ABR) of 0.00.</font></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.55pt">Latest results from the Phase 3 trial assessing </font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Dupixent</font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> in children aged 1 to 11 years with </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">eosinophilic esophagitis</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (EoE) met its primary endpoint of histological disease remission at 16 weeks with both higher and lower dose weight-tiered regimens. </font></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.55pt">The </font><font style="color:#0000ff;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Lancet</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> published positive results from a Phase 3 trial evaluating </font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Dupixent</font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">in children aged 6 months to 5 years with </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">uncontrolled moderate-to-severe atopic dermatitis</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, demonstrating that adding Dupixent</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> to low-potency topical corticosteroids (TCS) significantly improved skin clearance and reduced overall disease severity and itch compared to TCS alone (placebo) at 16 weeks. These data were the basis for the FDA approval and for a regulatory submission currently under review by the European Medicines Agency.</font></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.55pt">The Phase 3, open-label study comparing subcutaneous to intravenous administration of </font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Sarclisa</font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">in combination with pomalidomide and dexamethasone (Pd) in </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Relapsed, Refractory Multiple Myeloma </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(RRMM) patients who have received at least 1 prior line of therapy (IRAKLIA) enrolled its first participants.</font></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.55pt">The global clinical development program of </font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">amcenestrant</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, an investigational oral selective estrogen receptor degrader (SERD) was discontinued, based on the outcome of a prespecified interim analysis of the Phase 3 AMEERA-5 trial evaluating amcenestrant in combination with palbociclib in patients with </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">estrogen receptor-positive advanced breast cancer</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. An Independent Data Monitoring Committee (IDMC) found that amcenestrant in combination with palbociclib did not meet the prespecified boundary for continuation in comparison with the control </font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  9                   </font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.5pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">arm and recommended stopping the trial. No new safety signals were observed. All studies of amcenestrant, including in early-stage breast cancer (AMEERA-6), will be discontinued.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.55pt">Phase 3 trials in relapsing multiple sclerosis (RRMS) for</font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"> tolebrutinib</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, GEMINI 1 and GEMINI 2, reached their respective target enrollment. HERCULES for </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">non-relapsing secondary progressive MS</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (nrSPMS), PERSEUS for </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">primary progressive MS </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(PPMS) and URSA for </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">myasthenia gravis</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (MG) are resuming enrollment worldwide per countries&#8217; local regulations. Close to 2,100 enrolled patients around the globe are receiving tolebrutinib treatment, including in the U.S. </font></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:110%">Following written notification from the FDA in July requesting additional data, Sanofi provided the requested information with the aim to lift the partial clinical hold (recruitment pause), which could occur as early as Q4 2022. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Phase 2&#58;</font></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.55pt">A double-blinded, four-armed dose-ranging study evaluating </font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">amlitelimab</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (anti-OX40L mAb) as </font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">add-on therapy</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> was initiated in adult participants with moderate-to-severe asthma.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.8pt">Based on emerging external and internal data about non-alpha IL2&#8217;s mechanism of action and therapeutic potential, a new Phase 1&#47;2 program is planned to be initiated for </font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">SAR444245</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, focused on schedule intensification to solidify the foundation for a best -in -class target profile. In parallel, the decision was made to discontinue the ongoing phase 2 platform trials with the current every 3-week dose schedule as the efficacy observed in the early look of the data was lower than projected. Note that this decision was not based on any safety-related issues. </font></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:103%">Phase 1&#58;</font></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.55pt">The study evaluating </font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">SAR444200</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (anti-GPC3&#47;TCR Nanobody</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> VHH) in patients with </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">solid tumors</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> enrolled its first participants. </font></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.55pt">The development programs for </font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">SAR443726</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (anti-IL-13&#47;OX40L Nanobody</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> VHH) in </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">atopic dermatitis</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and </font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">SAR442999 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(anti-TNFa&#47;IL-23A Nanobody</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> VHH) in an </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">inflammatory indication</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> were discontinued due to their clinical profile and portfolio considerations.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#23004c;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Acquisitions and major collaborations</font></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.55pt">Sanofi and Innovent Biologics announced a </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">collaboration</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> to bring innovative medicines to patients in China with difficult-to-treat cancers. Both companies are committed to accelerating the development and commercialization of two Sanofi key clinical stage oncology assets&#58; Phase 3 </font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">tusamitamab ravtansine</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (anti-CEACAM5 ADC) and Phase 2 </font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">SAR444245</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (non-alpha IL-2), combining with Innovent&#8217;s sintilimab (anti-PD-1), the leading checkpoint inhibitor in China.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">An update of the R&#38;D pipeline at as of Sep 30, 2022, is available on our website&#58;</font></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:18pt"><font style="color:#7a00e6;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">https&#58;&#47;&#47;www.sanofi.com&#47;en&#47;science-and-innovation&#47;research-and-development </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font><br></font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  10                   </font></div></div></div><div id="i410bda0d322d42a2b8a6ead5105a1298_82"></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:115%">Progress on implementation of the Corporate Social Responsibility strategy</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#23004c;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Embedding CSR into Sanofi&#8217;s corporate culture with the Leaders to Citizens program </font></div><div style="margin-bottom:3pt;margin-top:6pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Leaders to Citizens program</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Leaders to Citizens program is part of the In and beyond the workplace CSR pillar. The objective of the program is to engage leaders to become active CSR catalysts and continue building CSR into our operations. It takes place in 2 phases&#58; </font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.55pt">Following an online learning to build awareness on CSR in the pharma industry</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.55pt">Leading a CSR project embedding social and environmental considerations in their day to day work</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The objectives of the program are to&#58;</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.55pt">Enhance skills and capabilities of leaders to help address global societal challenges </font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.55pt">Empower leaders to serve as agents of transformation by building confidence and proficiency on CSR issues</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.55pt">Be a catalyst of the Sanofi CSR strategy</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#23004c;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Sanofi continues its progress to improve access to medicines</font></div><div style="margin-bottom:3pt;margin-top:6pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">New report highlights Sanofi's work to improve access to insulins in LMIC</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On October 6, the Access to Medicine Foundation published a special report on access to diabetes care, one century on from the discovery of insulin, to highlight the need to scale up efforts to expand access to insulins. The report emphasizes the need for access not only to human insulins, but also analogue insulins, which were added to the List of Essential Medicines (EML) in 2021. The r</font><font style="color:#221e1f;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">eport highlights the move from &#8216;a patchwork of approaches&#8217; on a project basis and with limited scale and reach, to a more sustainable, systemic approaches to expanding access to insulin in LMICs.</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Sanofi is named as the only company focusing its access approach on analogue insulins (Lantus</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and Toujeo</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">) and partially on markets with severely limited access to insulin such as Tuvalu, Haiti and Guinea- Bissau via Sanofi Global Health. The report also acknowledges Sanofi&#8217;s commitment to make its glargine the first analogue insulin to be submitted for WHO prequalification in 2022, as an important step in expanding access to this essential product, which could encourage others to also pursue this route with their analogue insulins.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The report mentions the KiDS program, a partnership between Sanofi and the International Diabetes Federation (IDF) for pursuing local policy changes regarding the management of type 1 diabetes and prevention strategies for type 2 diabetes in children.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#23004c;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Sanofi continues its progress to limit its impact on the environment</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Climate change is one of the most pressing challenges of our time, and Sanofi has set clear ambitions &#58; carbon neutrality by 2030 and Net Zero by 2050. Towards Net Zero, Sanofi&#8217;s approach is two-fold&#58; reduce emissions across our full value chain as a priority and offset what cannot be reduced. Sanofi has set up an action plan on how to reduce its emissions in the following areas&#58; reducing GHG emissions from its activities, sourcing renewable energies, fostering an eco-fleet, and working with suppliers and partners to reduce GHG emissions across its full value chain. </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In parallel to our reduction efforts, Sanofi has developed a carbon offsetting strategy to address what remains post-reduction efforts. Sanofi has developed a community-focused carbon offsetting program that will not only remove or avoid emissions from the atmosphere, but Sanofi is also seeking balance between projects generating high volumes of credits and delivering positive impact on communities and co-benefits on environment. </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This year, Sanofi is focusing on two projects in partnership with EcoAct, an Atos company.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Sanofi is supporting the &#8220;Dziva Project&#8221;, an energy-efficiency project developed by EcoAct and its local partner. The project will provide 18,250 energy-saving biomass cookstoves to rural households in Kwale County, Kenya reducing the pressure on natural resources from inefficient traditional fuel cookstoves. By reducing fuelwood consumption by 60%, the project will avoid the emission of approximately 790ktCO2e in the atmosphere over its lifetime and improve living and social conditions of local rural families.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Additionally, Sanofi will also support a blue carbon project aiming to restore 500 hectares of degraded mangroves through the maintenance of tree nurseries, reforestation activities, and subsequent employment of scouts to patrol the recovered area. The project will remove an estimated 390ktCO2e over </font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  11                   </font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">its lifetime and contribute to the preservation of the mangrove ecosystem and the services it provides to both marine and terrestrial biodiversity and communities. This project is awaiting approval from national authorities. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In addition to reducing GHG emissions (cookstove) and sequestering CO2 (mangrove), these projects will generate both social and environmental benefits such as improving biodiversity, reducing disease related to smoke inhalation and time spent collecting wood and additional income from sustainable exploitation of mangrove timber for example.</font></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><font style="color:#23004c;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:700;line-height:102%">ESG dashboard</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In 2020, as Sanofi renewed its CSR ambitions, the Company reviewed and updated its portfolio of initiatives. Numbers shown below highlight the ongoing progress in the implementation of Sanofi&#8217;s integrated CSR strategy. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Data in YTD unless stated otherwise</font></div><div style="margin-bottom:3pt;margin-top:6pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Affordable access</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Sanofi Global Health, a non-profit unit formed within the company in April 2021, aims to provide 30 of Sanofi's medicines across a wide range of therapeutic areas to patients in 40 of the lowest income countries. Beyond the products provided through the impact</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> brand launched in July 2022, Sanofi Global Health works on integrating programs that ensure optimal care management over time for patients. In addition, an impact fund was created to fund and scale up promising business models. </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Sanofi is also committed to helping 1,000 patients living with rare diseases who have no access to treatments and will donate 100,000 vials of medicine for their treatments each year. This continues Sanofi&#8217;s 30-year commitment to patients suffering from rare diseases, such as Fabry, Gaucher or Pompe diseases, for which access to treatment is often limited. </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The third initiative on access is to develop a global access plan for all new products, making them available in selected relevant markets within two years of launch. </font></div><div><font><br></font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.928%"><tr><td style="width:1.0%"></td><td style="width:33.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Affordable access</font></div></td><td colspan="3" style="background-color:#23004c;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#23004c;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Sanofi Global Health</font></div></td></tr><tr><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:36pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Q2 2022</font></div></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:36pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Q3 2022</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Malaria</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:11.46pt">1,693,770 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">patients treated</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:11.46pt">10</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> countries</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:11.46pt">2,000,995 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">patients treated</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:11.46pt">13</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> countries</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Tuberculosis</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:11.46pt">76,634 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">patients treated</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:11.46pt">13 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">countries</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:11.46pt">98,542 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">patients treated</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:11.46pt">13</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> countries</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">NCD</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:11.46pt">85,956 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">patients treated</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:11.46pt">21 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">countries</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:11.46pt">109,934 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">patients treated</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:11.46pt">24 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">countries</font></div></td></tr><tr><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Rare disease vials donation</font></div></td></tr><tr><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:36pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Q2 2022</font></div></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:36pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Q3 2022</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"># Patients treated</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">1,015</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">1,064</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">#Vials donated</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">51,370</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">76,494</font></td></tr><tr><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Global access Plan</font></div></td></tr><tr><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:36pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Q2 2022</font></div></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:36pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Q3 2022</font></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"># of access plan</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pilot phase and blueprint completed</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Governance in place and roll-out across all business units</font></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">R&#38;D for unmet needs</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Sanofi continues its efforts to fight polio and sleeping sickness, two of its legacy programs that address global health issues. </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Sanofi continues to play a critical role in the delivery of polio vaccines. The Company has also committed to collaborate with WHO to eliminate sleeping sickness by 2030. Part of Sanofi&#8217;s R&#38;D ambition is to develop innovative medicines to eliminate cancer deaths in children</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  12                   </font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font><br></font></div><div style="margin-bottom:3pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.279%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="background-color:#23004c;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">R&#38;D for unmet needs</font></div></td></tr><tr><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Eradicate Polio</font></div></td></tr><tr><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Q2 2022</font></div></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Q3 2022</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"># Inactivated Polio Vaccine (IPV) doses supplied</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">27 million</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> IPV doses supplied to UNICEF for GAVI countries</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">38 million </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">IPV doses supplied to UNICEF for GAVI countries</font></div><div style="text-indent:36pt"><font><br></font></div></td></tr><tr><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Sleeping sickness elimination</font></div><div style="text-align:center"><font><br></font></div></td></tr><tr><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">FY 2021</font></div></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Q3 2022</font></div></td></tr><tr style="height:23pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"># Patients tested</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">2 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">million</font></div></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Data updated annually</font></td></tr><tr style="height:21pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"># Patients treated</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">805</font></td></tr><tr><td colspan="9" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Pediatric cancer treatment development</font></div></td></tr><tr><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Q2 2022</font></div></td><td colspan="3" style="background-color:#f2f2f2;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Q3 2022</font></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"># of assets identified</font></div></td><td colspan="6" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:12.55pt">1 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">asset in</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> pre-clinical assessments</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:12.55pt">1 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">asset in protocol</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> preparation for clinical study</font></div></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Planet care</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">To contribute to better resource conservation, Sanofi plans to remove all plastic blister packs for its syringe vaccines by 2027. In addition, the company is committed to eco-designing all its new products by 2025. To reduce its GHG emissions by 55% by 2030, all Sanofi sites will use 100% electricity from renewable sources and the Company has set a target of a carbon-neutral for its car fleet, both by 2030. </font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.977%"><tr><td style="width:1.0%"></td><td style="width:20.129%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.129%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.531%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.811%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="background-color:#23004c;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Planet Care</font></div></td></tr><tr><td colspan="12" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Blister free vaccines</font></div></td></tr><tr><td colspan="6" style="background-color:#f4f2f6;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Q2 2022</font></div></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Q3 2022</font></div></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">% blister free syringe vaccines</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">29%</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of blister free syringe produced</font></div><div style="text-indent:36pt"><font><br></font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Data updated annually</font></div></td></tr><tr><td colspan="12" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Eco design</font></div></td></tr><tr><td colspan="6" style="background-color:#f4f2f6;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Q2 2022</font></div></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Q3 2022</font></div></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"># of Life Cycle Analysis (LCA)</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">5 LCAs completed &#38; 3 in progress</font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Eco-design digital solutions project in progress</font></div><div><font><br></font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">7 LCAs completed &#38; 1 in progress</font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Eco-design digital solutions project in progress</font></div></td></tr><tr><td colspan="12" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Scope 1 &#38; 2 emissions</font></div></td></tr><tr><td colspan="6" style="background-color:#f4f2f6;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Q2 2022</font></div></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Q3 2022</font></div></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">GHG reduction vs 2019 %</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">-27%</font></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">-28%</font></td></tr><tr><td colspan="12" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Renewable electricity</font></div><div style="text-align:center"><font><br></font></div></td></tr><tr><td colspan="6" style="background-color:#f4f2f6;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Q2 2022</font></div></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Q3 2022</font></div></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">% electricity consumption from renewable sources</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">60.0%</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">61.4%</font></td></tr><tr><td colspan="12" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Eco car fleet</font></div></td></tr><tr><td colspan="6" style="background-color:#f4f2f6;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Q2 2022</font></div></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Q3 2022</font></div></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">% eco car fleet on total car fleet</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">30.4%</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> eco-fleet</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">32.7% </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">eco-fleet</font></div></td></tr></table></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:120%">In and beyond the workplace</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As a global company, Sanofi is committed to ensuring that its leaders reflect the communities and patients it serves. The Company is committed to continue fostering an organization where all employees have equal opportunities to reach positions of responsibility within the company. Sanofi&#8217;s ambition is to have 40% of women in top executive roles and 50% of women in senior leadership roles by 2025. Sanofi is continuing its social and economic engagement in the communities it operates in. Finally, Sanofi is embedding its commitment to society in its leaders&#8217; career development paths to strengthen the social impact of their decisions.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  13                   </font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.698%"><tr><td style="width:1.0%"></td><td style="width:18.928%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.928%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.482%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.232%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#23004c;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:11pt;font-weight:700;line-height:112%">In and beyond the workplace</font></div></td></tr><tr><td colspan="9" style="background-color:#f4f2f6;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Q2 2022</font></div></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Q3 2022</font></div></td></tr><tr><td colspan="15" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Diverse Senior Leadership</font></div></td></tr><tr><td colspan="9" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">% of women</font></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">35.9% </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">of our executives</font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">41.1% </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">of our senior leaders were women</font></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">36.2% </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">of our executives</font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:112%">41.4% </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">of our senior leaders were women</font></div></td></tr><tr><td colspan="15" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Engagement with communities</font></div></td></tr><tr><td colspan="9" style="background-color:#f4f2f6;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Q2 2022</font></div></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Q3 2022</font></div></td></tr><tr><td colspan="9" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"># volunteers</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">1,998</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> volunteers</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">3,498</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> volunteers</font></div></td></tr><tr><td colspan="9" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"># hours</font></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">12,687</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> hours</font></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">25,265</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> hours</font></div></td></tr><tr><td colspan="15" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">From Leaders to Citizens</font></div></td></tr><tr><td colspan="9" style="background-color:#f4f2f6;border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Q2 2022</font></div></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Q3 2022</font></div></td></tr><tr><td colspan="9" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">KPI</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Roll out planned in 2022</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Program launched</font></td></tr></table></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#23004c;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:700;line-height:102%">ESG ratings</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><img alt="esg251022.jpg" src="esg251022.jpg" style="height:310px;margin-bottom:5pt;vertical-align:text-bottom;width:716px"></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  14                   </font></div></div></div><div id="i410bda0d322d42a2b8a6ead5105a1298_85"></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:115%">Third-quarter and first-nine months 2022 financial results</font></div><div style="margin-top:3pt"><font style="color:#23004c;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Business Net Income</font><font style="color:#23004c;font-family:'Verdana',sans-serif;font-size:7.8pt;font-weight:700;line-height:115%;position:relative;top:-4.2pt;vertical-align:baseline">4</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the third quarter of 2022, Sanofi generated</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> net sales</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of &#8364;12,482 million, an increase of 19.7% (up 9.0% at CER). First-nine months  net sales were &#8364;32,272 million up 16.2% (up 8.6% at CER).</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Third-quarter </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">other revenues</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> increased 65.2% (up 41.1% at CER) to &#8364;656 million, including increased VaxServe sales of non-Sanofi products of &#8364;475 million (up 20.5% at CER). In the first nine months, other revenues increased 67.3% (up 49.2% at CER) to &#8364;1,661 million, including VaxServe sales of non-Sanofi products of &#8364;1 154 million (up 28.9% at CER).</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Third-quarter </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Gross Profit</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> increased 22.6% (up 10.3% at CER) to &#8364;9,307 million. The gross margin ratio increased 1.8 percentage point to 74.6% versus the same period of 2021, reflecting positive currency effect, strong improvement of the Pharmaceuticals gross margin ratio (which increased from 75.2% to 77.2%) and Vaccines (to 74.1% from 72.0%) driven by favorable product mix and efficiency gains. CHC gross margin ratio was 64.4%, down 0.3 percentage point. In the first nine months, the gross margin ratio increased 2.3 percentage points to 74.3% (73.6% at CER) driven by Pharmaceuticals and Vaccines.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Research and Development </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(R&#38;D)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">expenses were up 20.2% (up 12.7% at CER) to &#8364;1,736 million in the third quarter, reflecting increased expenses in pharmaceuticals priority assets and early-stage projects as well as in Vaccines. In the first nine months, R&#38;D expenses increased 18.9% to &#8364;4,883 million (up 13.1% at CER). </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Third-quarter </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">selling general and administrative expenses</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (SG&#38;A) increased 16.7% to &#8364;2,644 million. At CER, SG&#38;A expenses were up 6.8%, reflecting increased commercial investments in Specialty Care growth drivers coupled with acceleration of cloud migration and application development. In the third quarter, the ratio of SG&#38;A to sales decreased 0.5 percentage point to 21.2% compared to the prior year. In the first nine months, SG&#38;A expenses increased 11.8% to &#8364;7,597 million (up 4.6% at CER) and the ratio of SG&#38;A to sales was 1.0 percentage point lower at 23.5% compared to the same period of 2021.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Third-quarter and first-nine months </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">operating expenses</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> were &#8364;4,380 million, (up 18.1% and 9.1% at CER) and &#8364;12,480 million (up 14.5% and 7.8% at CER).</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Third-quarter </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">other current operating income net of expenses</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> was &#8364;-450 million versus &#8364;-291 million in the third quarter of 2021. Other current operating income net of expenses included an expense of &#8364;610 million (versus an expense of &#8364;399 million in the third quarter of 2021) corresponding to the share of profit to Regeneron of the monoclonal antibodies Alliance, additional share of profit paid by Regeneron towards development costs and the reimbursement of commercialization-related expenses incurred by Regeneron. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Following the amended Antibody collaboration, Regeneron increased from 10% to 20% the share of its profits that are paid to Sanofi to reimburse Sanofi-funded development expenses from April 1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.47pt;font-weight:400;line-height:115%;position:relative;top:-3.48pt;vertical-align:baseline">st.</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9.96pt;font-weight:400;line-height:115%">. As a result, </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">a true-up (&#8364;57 million) reflecting this retroactive effect was recorded in this line in the third quarter. The other current operating income net of expenses also included the royalties received on Libtayo</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> sales in the third quarter and a true-up reflecting retroactive effect related to the second quarter.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the third quarter, this line also included &#8364;132 million of net capital gains related to General Medicines and CHC portfolio streamlining compared to &#8364;154 million in the same period of 2021. In the first nine months of 2022, other current operating income net of expenses was &#8364;-1,238 million versus &#8364;-590 million in the same period of 2021 and included &#8364;388 million of net capital gains related to portfolio streamlining compared to &#8364;257 million in the same period of 2021. </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The third-quarter and first-nine months </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">share of profit from associates </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">was &#8364;27 million and &#8364;82 million versus &#8364;-5 million and &#8364;21 million in the same periods of 2021, respectively, and included the share of U.S profit related to Vaxelis</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Third-quarter </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">business operating income</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:700;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">4</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (BOI) increased 26.5% to &#8364;4,498 million. At CER, BOI increased 13.0%. The ratio of BOI to net sales increased 1.9 percentage point to 36.0% reflecting gross margin improvement. In the first nine months, BOI was &#8364;10,316 million, up 22.0% (up 12.8% at CER). In the first nine months, the ratio of business operating income to net sales increased 1.5 percentage point to 32.0% (31.6% at CER).</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Net financial expenses</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> were &#8364;-51 million and &#8364;-206 million in the third quarter and the first nine months of 2022, respectively, versus &#8364;-85 million and &#8364;-245 million in the same periods of 2021. </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Third-quarter and first-nine months 2022 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">effective tax rate</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> was 19.0% versus 21.0% in the prior year. Sanofi expects its effective tax rate to be around 19% in 2022.</font></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">S</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">ee Appendix 3 for 2022 third-quarter consolidated income statement&#59; see Appendix 7 for definitions of financial indicators, and Appendix 4 for reconciliation of IFRS net income reported to business net income</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">. </font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  15                   </font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Third-quarter </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">business net income</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">4</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> increased 31.8% to &#8364;3,606 million and increased 17.7% at CER. The ratio of business net income to net sales increased 2.7 percentage points to 28.9% versus the third quarter of 2021. In the first nine months of 2022, business net income increased 26.5% to &#8364;8,200 million and increased 16.9% at CER. The ratio of business net income to net sales increased 2.1 percentage points to 25.4% versus the same period of 2021.</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the third quarter of 2022,</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> business earnings per share</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:700;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">4</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(EPS) was &#8364;2.88, up 32.1% on a reported basis (up 17.9% at CER). The average number of shares outstanding was 1,253.5 million versus 1,254.5 million in the third quarter of 2021. In the first nine months of 2022, business earnings per share</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.47pt;font-weight:400;line-height:115%;position:relative;top:-3.48pt;vertical-align:baseline">8</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> was &#8364;6.55, up 26.4% on a reported basis and up 17.0% at CER. The average number of shares outstanding was 1,251.2 million versus 1,251.7 million in the first nine months of 2021.</font></div><div id="i410bda0d322d42a2b8a6ead5105a1298_88"></div><div style="margin-top:6pt;text-align:justify"><font><br></font></div><div><font style="color:#23004c;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Reconciliation of IFRS net income reported to business net income (see Appendix 4) </font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the first nine months of 2022, the IFRS net income was &#8364;5,260 million</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:115%">. </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The main items excluded from the business net income were&#58;</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:12.55pt">An amortization charge of &#8364;1,370 million related to fair value remeasurement on intangible assets of acquired companies (primarily Genzyme&#58; &#8364;405 million, Bioverativ&#58; &#8364;278 million, Boehringer Ingelheim CHC business&#58; &#8364;142 million, Ablynx&#58; &#8364;126 million and Kadmon&#58; &#8364;118 million and to acquired intangible assets (licenses&#47;products&#58; &#8364;82 million). These items have no cash impact on the Company.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.53pt">An impairment of intangible assets of &#8364;1,673 million o</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">f which &#8364;1,586 million are </font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">related to SAR444245, a </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">non-alpha IL2,</font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> based on emerging external and internal data that </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:112%">led to updated cash flow projections due to delays in launch timelines in key indications.</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:12.55pt">An upfront payment of $900 million net of the carrying value of Libtayo</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> intangible assets related to the restructuring of the immuno-oncology collaboration with Regeneron Pharmaceuticals, Inc. (income of &#8364;630 million)</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:12.55pt">Restructuring costs and similar items of &#8364;1,166 million related to streamlining initiatives.</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:12.55pt">A &#8364;814 million tax effect arising from the items listed above, mainly comprising &#8364;628 million of deferred taxes generated by amortization and impairments of intangible assets and</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> &#8364;201 </font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">million associated with restructuring costs and similar items (see Appendix 4). </font></div><div style="margin-top:3pt;text-align:justify"><font><br></font></div><div><font style="color:#23004c;font-family:'Verdana',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Capital Allocation</font></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In the first nine months of 2022, free cash flow before restructuring, acquisitions and disposals decreased by 4.2% to &#8364;6,677 million, after net changes in working capital </font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(&#8364;-999 milli</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">on) and capital expenditures (&#8364;-1,100 million). After acquisitions</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (&#8364;-544 million</font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, proceeds from disposals</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (&#8364;676 million) and payments related to restructuring and similar items (-&#8364;872 million), </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">free cash flow</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> increased 6.9%</font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">to &#8364;5,937 million. After the acquisition of Amunix (-&#8364;875 million), the dividend paid by Sanofi (-&#8364;4,168 million), net debt decreased from &#8364;9,983 million at December 31, 2021 to &#8364;8,748 million at September 30, 2022 (amount </font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">net of &#8364;10</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">,493 </font><font style="background-color:#ffffff;color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">milli</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:115%">on cash and cash equivalents).</font></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">Not exceeding &#8364;500 million per transaction (inclusive of all payments related to the transaction).</font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">non-GAAP financial measure (definition in Appendix 7).</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  16                   </font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="text-align:justify;text-indent:216pt"><font><br></font></div><div id="i410bda0d322d42a2b8a6ead5105a1298_97"></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Forward-Looking Statements</font></div><div style="text-align:justify"><font style="color:#404040;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:112%">This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These statements include projections and estimates and their underlying assumptions, statements regarding plans, objectives, intentions and expectations with respect to future financial results, events, operations, services, product development and potential, and statements regarding future performance. Forward-looking statements are generally identified by the words &#8220;expects&#8221;, &#8220;anticipates&#8221;, &#8220;believes&#8221;, &#8220;intends&#8221;, &#8220;estimates&#8221;, &#8220;plans&#8221; and similar expressions. Although Sanofi&#8217;s management believes that the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of Sanofi, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include among other things, the uncertainties inherent in research and development, future clinical data and analysis, including post marketing, decisions by regulatory authorities, such as the FDA or the EMA, regarding whether and when to approve any drug, device or biological application that may be filed for any such product candidates as well as their decisions regarding labelling and other matters that could affect the availability or commercial potential of such product candidates, the fact that product candidates if approved may not be commercially successful, the future approval and commercial success of therapeutic alternatives, Sanofi&#8217;s ability to benefit from external growth opportunities, to complete related transactions and&#47;or obtain regulatory clearances, risks associated with intellectual property and any related pending or future litigation and the ultimate outcome of such litigation, trends in exchange rates and prevailing interest rates, volatile economic and market conditions, cost containment initiatives and subsequent changes thereto, and the impact that COVID-19 will have on us, our customers, suppliers, vendors, and other business partners, and the financial condition of any one of them, as well as on our employees and on the global economy as a whole. The risks and uncertainties also include the uncertainties discussed or identified in the public filings with the SEC and the AMF made by Sanofi, including those listed under &#8220;Risk Factors&#8221; and &#8220;Cautionary Statement Regarding Forward-Looking Statements&#8221; in Sanofi&#8217;s annual report on Form 20-F for the year ended December 31, 2021. Other than as required by applicable law, Sanofi does not undertake any obligation to update or revise any forward-looking information or statements.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font><br></font></div><div id="i410bda0d322d42a2b8a6ead5105a1298_100"></div><div><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:16pt;font-style:italic;font-weight:400;line-height:115%">Appendices</font></div><div><font><br></font></div><div style="margin-bottom:1pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.419%"><tr><td style="width:1.0%"></td><td style="width:11.961%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.839%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Appendix&#160;1&#58;&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third-quarter and first nine months 2022 sales by GBU, franchise, geographic region and product</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i410bda0d322d42a2b8a6ead5105a1298_109" style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">Appendix 2&#58;</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third- quarter<a href="#i410bda0d322d42a2b8a6ead5105a1298_109" style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none"> </a>and first nine months <a href="#i410bda0d322d42a2b8a6ead5105a1298_109" style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">2022 business net income statement</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i410bda0d322d42a2b8a6ead5105a1298_115" style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">Appendix 3&#58;</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third-quarter and first nine months <a href="#i410bda0d322d42a2b8a6ead5105a1298_115" style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">2022 consolidated income statement</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i410bda0d322d42a2b8a6ead5105a1298_118" style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">Appendix 4&#58;</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i410bda0d322d42a2b8a6ead5105a1298_118" style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">Reconciliation of IFRS net income reported to business net income</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:174%"><a href="#i410bda0d322d42a2b8a6ead5105a1298_121" style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:174%;text-decoration:none">Appendix 5&#58;</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:174%"><a href="#i410bda0d322d42a2b8a6ead5105a1298_121" style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:174%;text-decoration:none">Change in net debt</a></font></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Appendix 6&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency sensitivity</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i410bda0d322d42a2b8a6ead5105a1298_136" style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">Appendix </a>7&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i410bda0d322d42a2b8a6ead5105a1298_136" style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">Definitions of non-GAAP financial indicators</a></font></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:1pt"><font><br></font></div><div style="text-align:justify"><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Media Relations</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Sandrine Guendoul </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#124; + 33 6 25 09 14 25 &#124; </font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">sandrine.guendoul&#64;sanofi.com</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Sally Bain </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#124; + 1 617 834 6026 &#124; </font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">sally.bain&#64;sanofi.com</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Chrystel Baude </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#124; + 33 6 70 98 70 59 &#124; </font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">chrystel.baude&#64;sanofi.com</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Evan Berland</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%"> &#124; +1 215 432 0234 &#124; </font><font style="color:#5400b8;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">evan.berland&#64;sanofi.com</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Nicolas Obrist </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#124; + 33 6 77 21 27 55 &#124; </font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">nicolas.obrist&#64;sanofi.com</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Victor Rouault </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#124; + 33 6 70 93 71 40 &#124; </font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">victor.rouault&#64;sanofi.com</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Kate Conway </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#124; + 1 508 364 4931 &#124; </font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">kate.conway&#64;sanofi.com</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Investor Relations</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Eva Schaefer-Jansen </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#124; + 33 7 86 80 56 39 &#124; </font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">eva.schaefer-jansen&#64;sanofi.com </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Arnaud Del&#233;pine </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#124; + 33 6 73 69 36 93 &#124; </font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">arnaud.delepine&#64;sanofi.com</font><font style="color:#7a00e6;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Corentine Driancourt </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#124; + 33 6 40 56 92 21 &#124; </font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">corentine.driancourt&#64;sanofi.com </font><font style="color:#7a00e6;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Felix Lauscher </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#124; + 1 908 612 7239 &#124; </font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">felix.lauscher&#64;sanofi.com </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Priya Nanduri </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#124; +1 617 764 6418 &#124; </font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">priya.nanduri&#64;sanofi.com  </font><font style="color:#7a00e6;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Nathalie Pham </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#124; + 33 7 85 93 30 17 &#124; </font><font style="color:#7a00e6;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:112%">nathalie.pham&#64;sanofi.com</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  17                   </font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div id="i410bda0d322d42a2b8a6ead5105a1298_106"></div><div><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">Appendix 1&#58; 2022 third-quarter and first-nine months net sales by GBU, franchise, geographic region and product</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.977%"><tr><td style="width:1.0%"></td><td style="width:21.805%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.279%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.279%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.279%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.358%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.279%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.279%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.358%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.279%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.279%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.358%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.279%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.289%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q3 2022<br>(&#8364; million)</font></td><td colspan="3" style="background-color:#23004c;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Sales</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% CER</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% reported</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">United States</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% CER</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Europe</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% CER</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Rest of the world</font></td><td colspan="3" style="background-color:#23004c;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% CER</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dupixent</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,314</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+44.5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+64.1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,803</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+45.1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">241</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+38.7</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">270</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+46.6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Aubagio</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">521</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-3.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+7.9&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">374</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-2.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">119</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-1.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">28</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-24.2&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Lemtrada</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">18</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-20.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-10.0&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">7</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-33.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">5</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-28.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">6</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+25.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Kevzara</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">88</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-2.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+6.0&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">52</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-10.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">28</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+12.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">8</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Neurology &#38; Immunology</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">627</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-4.1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+7.0</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">433</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-4.1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">152</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-0.7</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">42</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-14.9</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Cerezyme</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">181</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+8.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+13.8&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">50</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-4.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">57</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-3.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">74</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+32.7&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Cerdelga</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">78</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+10.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+21.9&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">45</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+18.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">28</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+7.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">5</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-20.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Myozyme</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">255</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-10.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-4.1&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">82</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-33.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">103</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-1.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">70</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+15.5&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Nexviazyme</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">58</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+4900.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+5700.0&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">46</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+3900.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">6</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">6</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Fabrazyme</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">240</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+5.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+14.8&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">127</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+7.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">54</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+1.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">59</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+5.5&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Aldurazyme</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">69</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+15.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+21.1&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">16</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+7.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">20</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">33</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+33.3&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Rare Disease</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">900</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+7.7</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+15.5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">367</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+6.1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">269</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+1.5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">264</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+17.4</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Jevtana</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">101</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-13.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-3.8&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">74</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">7</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-65.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">20</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-4.5&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Fasturtec</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">44</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+10.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+18.9&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">28</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+9.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">12</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+66.7&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Libtayo</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-100.0&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-100.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Sarclisa</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">79</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+54.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+64.6&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">37</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+72.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">23</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+35.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">19</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+53.8&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Oncology</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">224</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-8.4</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-0.4</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">139</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+14.6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">41</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-45.5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">44</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+2.2</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Alprolix</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">126</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+8.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+24.8&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">107</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+10.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">19</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Eloctate</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">151</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-7.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+4.9&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">121</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-7.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">30</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-9.1&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Cablivi</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">52</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+14.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+23.8&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">26</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+10.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">25</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+9.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+200.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Rare Blood Disorder</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">336</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+3.5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+17.1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">260</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+3.3</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">25</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+9.1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">51</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+1.9</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Specialty Care</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,401</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+19.9</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+33.9</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,002</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+24.4</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">728</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+5.4</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">671</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+21.3</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Lovenox</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">307</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-23.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-19.8&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">7</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-33.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">151</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-7.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">149</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-35.1&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Toujeo</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">304</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+17.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+27.2&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">86</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+2.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">104</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+8.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">114</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+43.7&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Plavix</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">230</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-1.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+3.6&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">24</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-14.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">204</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+0.5&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Multaq</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">101</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+10.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+27.8&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">93</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+12.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-20.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Thymoglobulin</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">118</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+15.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+29.7&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">72</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+19.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">8</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-11.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">38</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+16.7&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Mozobil</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">68</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+1.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+13.3&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">42</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+9.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">18</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+12.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">8</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-36.4&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Praluent</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">83</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+33.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+40.7&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">56</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+34.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">27</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+33.3&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Soliqua&#47;iGlarLixi</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">54</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-5.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+5.9&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">33</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-6.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">7</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">14</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-7.1&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Rezurock</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">60</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">59</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Others core assets</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">261</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-2.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+3.2&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">46</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-30.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">85</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+4.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">130</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+5.2&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Core Assets</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,586</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+2.4</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+10.4</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">440</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+16.4</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">457</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+2.2</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">689</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-4.4</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Lantus</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">559</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-17.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-10.1&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">217</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-7.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">99</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-12.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">243</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-26.5&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Aprovel</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">129</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+11.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+20.6&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-75.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">20</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+5.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">107</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+16.7&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Others non-core assets</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,094</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-12.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-8.4&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">104</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-13.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">267</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-14.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">723</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-11.7&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-Core Assets</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,782</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-12.8</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-7.3</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">323</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-10.1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">386</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-12.9</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,073</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-13.6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Industrial Sales</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">127</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-43.3</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-38.9</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-77.8</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">122</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-40.3</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-61.5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">General Medicines</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,495</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-8.5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-2.0</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">765</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+2.3</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">965</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-11.3</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,765</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-10.6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pharmaceuticals</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">7,896</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+5.1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+15.2</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,767</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+19.2</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,693</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-4.8</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,436</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-3.4</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Polio &#47; Pertussis &#47; Hib</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">640</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+9.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+13.7&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">152</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+4.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">84</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+7.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">404</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+11.1&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Booster Vaccines</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">178</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+1.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+12.7&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">113</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-8.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">41</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+13.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">24</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+35.3&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Meningitis </font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">328</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+11.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+29.6&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">292</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+14.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">4</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">32</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-14.3&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Influenza Vaccines</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,994</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+32.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+48.9&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,321</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+14.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">396</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+60.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">277</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+132.7&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Travel and Endemic Vaccines</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">146</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+64.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+78.0&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">51</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+26.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">28</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+133.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">67</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+77.8&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Vaccines</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,315</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+23.5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+36.9</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,956</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+11.6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">554</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+48.7</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">805</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+38.2</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Allergy</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">160</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-0.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+12.7&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">99</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-8.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">11</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+25.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">50</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+11.9&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Cough and Cold</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">127</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+30.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+35.1&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">67</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+48.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">60</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+14.3&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Pain Care</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">292</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-3.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+0.7&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">53</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-15.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">125</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-0.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">114</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-1.8&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Digestive Wellness</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">351</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+14.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+24.5&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">37</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+6.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">101</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+3.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">213</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+23.1&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Physical Wellness</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">82</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-9.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-3.5&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">5</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-28.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">77</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-7.7&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Mental Wellness</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">60</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+1.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+13.2&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">13</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">25</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+13.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">22</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-10.5&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Personal Care</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">150</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-2.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+11.1&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">118</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-1.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-100.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">32</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-3.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Non-Core &#47; Others</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">49</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-35.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-33.8&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-66.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">15</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-33.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">35</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-34.1&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consumer Healthcare</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,271</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+1.9</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+10.0</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">319</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-5.9</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">349</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+5.1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">603</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+4.1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Company</font></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12,482</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">+9.0</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">+19.7</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6,042</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">+15.0</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,596</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">+4.6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,844</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">+4.5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-right:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td></tr></table><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%"> </font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  18                   </font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font><br></font></div><div style="margin-bottom:1pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.977%"><tr><td style="width:1.0%"></td><td style="width:21.805%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.279%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.279%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.279%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.358%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.279%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.279%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.358%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.279%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.279%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.358%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.279%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.289%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">First 9M 2022<br>(&#8364; million)</font></td><td colspan="3" style="background-color:#23004c;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Sales</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% CER</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% reported</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">United States</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% CER</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Europe</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% CER</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#23004c;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Rest of the world</font></td><td colspan="3" style="background-color:#23004c;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">% CER</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dupixent</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,891</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+44.5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+59.2</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,456</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+40.7</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">691</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+48.9</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">744</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+63.8</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Aubagio</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,538</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-4.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+4.1&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,063</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-5.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">388</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+0.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">87</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-14.4&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Lemtrada</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">63</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-6.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">26</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-20.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">17</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-5.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">20</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+18.8&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Kevzara</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">260</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+25.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+32.7&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">142</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+27.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">81</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+23.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">37</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+25.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Neurology &#38; Immunology</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,861</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-0.9</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+7.2</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,231</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-2.6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">486</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+3.4</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">144</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-2.1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Cerezyme</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">548</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+6.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+9.2&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">144</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">183</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">221</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+17.3&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Cerdelga</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">217</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+8.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+16.0&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">120</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+10.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">83</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+7.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">14</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Myozyme</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">742</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-5.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-0.9&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">245</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-23.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">309</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+1.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">188</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+12.4&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Nexviazyme</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">131</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+5800.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+6450.0&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">109</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+9500.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">9</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+700.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">13</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Fabrazyme</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">698</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+5.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+12.4&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">348</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+6.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">170</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+3.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">180</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+7.2&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Aldurazyme</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">202</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+8.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+12.2&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">45</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+2.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">65</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+3.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">92</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+15.4&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Rare Disease</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,595</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+7.1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+12.4</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,012</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+6.9</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">822</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+3.3</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">761</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+11.7</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Jevtana</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">304</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-18.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-11.9&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">216</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+5.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">26</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-72.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">62</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-7.4&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Fasturtec</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">130</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+9.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+17.1&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">82</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+12.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">36</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+5.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">12</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Libtayo</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">88</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-9.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-6.4&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">69</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-9.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">19</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-11.1&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Sarclisa</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">208</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+62.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+70.5&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">92</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+76.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">61</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+38.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">55</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+75.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Oncology</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">731</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+2.1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+8.8</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">390</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+18.1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">192</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-22.9</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">149</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+13.8</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Alprolix</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">363</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+9.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+20.6&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">305</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+10.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">58</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+1.8&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Eloctate</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">442</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-4.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+4.7&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">353</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-4.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">89</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-6.3&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Cablivi</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">149</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+11.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+18.3&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">74</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+4.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">72</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+14.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+100.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Rare Blood Disorder</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">965</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+3.7</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+13.7</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">742</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+3.6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">72</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+14.5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">151</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-0.7</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Specialty Care</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12,043</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+19.8</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+30.0</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">7,831</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+21.9</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,263</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+10.8</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,949</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+24.2</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Lovenox</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,021</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-14.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-11.3&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">14</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-50.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">504</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-5.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">503</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-20.6&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Toujeo</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">845</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+8.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+14.3&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">214</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-1.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">315</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+8.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">316</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+16.4&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Plavix</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">738</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-0.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+4.4&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">7</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-14.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">76</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-13.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">655</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+1.6&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Multaq</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">279</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+8.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+21.3&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">253</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+10.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">13</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-23.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">13</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+18.2&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Thymoglobulin</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">328</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+13.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+24.7&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">193</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+11.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">25</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">110</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+21.2&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Mozobil</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">192</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+4.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+12.9&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">113</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+7.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">49</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+8.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">30</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-9.4&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Praluent</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">280</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+63.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+71.8&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">55</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+860.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">164</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+39.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">61</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+33.3&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Soliqua&#47;iGlarLixi</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">160</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+4.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+13.5&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">89</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-4.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">22</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+4.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">49</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+24.3&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Rezurock</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">144</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">143</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Others core assets</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">804</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-1.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+3.7&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">132</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-34.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">267</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+4.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">405</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+11.8&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Core Assets</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,791</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+4.3</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+10.4</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,213</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+14.4</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,435</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+3.1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,143</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">+0.5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Lantus</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,830</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-10.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-4.2&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">642</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-9.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">322</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-10.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">866</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-11.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Aprovel</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">374</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+14.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+21.8&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">5</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-42.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">62</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-6.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">307</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+21.4&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Others non-core assets</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3,414</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-9.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-6.2&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">300</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-8.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">860</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-11.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2,254</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-8.7&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-Core Assets</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,618</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-8.5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-4.1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">947</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-9.3</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,244</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-10.9</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,427</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-7.3</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Industrial Sales</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">443</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-27.6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-24.7</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">15</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-60.6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">416</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-23.2</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">-61.8</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">General Medicines</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10,852</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-4.4</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+0.6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,175</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+1.5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,095</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-6.9</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,582</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-4.8</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pharmaceuticals</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">22,895</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+6.8</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+14.2</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10,006</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+16.8</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,358</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-0.2</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">7,531</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+1.4</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Polio &#47; Pertussis &#47; Hib</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,842</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+9.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+14.0&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">376</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-8.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">245</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+9.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,221</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+15.3&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Booster Vaccines</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">439</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+11.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+20.6&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">257</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+3.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">115</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+12.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">67</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+43.2&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Meningitis</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">593</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-6.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+4.6&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">477</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-2.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">10</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+900.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">106</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-26.2&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Influenza Vaccines</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2,175</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+26.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+41.7&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,333</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+15.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">433</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+63.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">409</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+33.0&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Travel and Endemic Vaccines</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">389</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+70.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+80.9&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">125</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+55.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">70</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+176.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">194</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+56.7&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Vaccines</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,513</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+16.5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+26.5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,634</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+7.5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">875</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+41.7</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,004</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+18.6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Allergy</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">578</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+9.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+19.2&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">348</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+6.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">48</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+11.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">182</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+13.9&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Cough and  Cold</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">346</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+66.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+69.6&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">189</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+107.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">157</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+32.7&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Pain Care</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">910</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+7.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+11.2&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">156</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-4.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">414</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+10.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">340</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+10.1&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Digestive Wellness</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,012</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+12.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+18.4&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">99</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-3.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">325</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+9.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">588</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+17.7&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Physical Wellness</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">255</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+4.5&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">16</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-20.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">239</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+1.8&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Mental Wellness</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">183</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+9.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+14.4&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">37</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-2.9&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">85</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+10.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">61</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+16.7&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Personal Care</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">429</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+0.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+10.9&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">327</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-0.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-66.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">101</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">+5.4&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Non-Core &#47; Others</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">151</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-27.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-26.0&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(3)</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-128.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">52</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-32.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">102</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">-17.1&#160;</font></td><td style="border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consumer Healthcare</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3,864</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+9.2</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+15.1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">964</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">-0.2</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,130</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+14.6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1,770</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">+11.1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-right:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</font></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-right:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Company</font></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-left:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">32,272</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">+8.6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">+16.2</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">13,604</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">+13.5</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">7,363</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">+5.6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">11,305</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">+5.6</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:2pt solid #000000;border-right:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</font></td></tr></table></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  19                   </font></div></div></div><div id="i410bda0d322d42a2b8a6ead5105a1298_109"></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Appendix 2&#58; Business net income statement</font></div><div style="margin-bottom:1pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.977%"><tr><td style="width:1.0%"></td><td style="width:14.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.184%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.184%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.067%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.486%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.486%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.486%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.486%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.184%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.358%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Third quarter 2022</font></td><td colspan="9" style="background-color:#23004c;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pharmaceuticals</font></td><td colspan="9" style="background-color:#23004c;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Vaccines</font></td><td colspan="9" style="background-color:#23004c;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consumer Healthcare</font></td><td colspan="9" style="background-color:#23004c;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Other</font><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</font></div></td><td colspan="9" style="background-color:#23004c;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Group</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8364; million</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Q3 2022</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Q3 2021 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(2)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">Change</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Q3 2022</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Q3 2021 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(2)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">Change</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Q3 2022</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Q3 2021 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(2)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">Change</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Q3 2022</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Q3 2021 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(2)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">Change</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Q3 2022</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Q3 2021 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(2)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">Change</font></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net sales</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">7,896</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">6,855</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">15.2%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">3,315</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2,422</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">36.9%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">1,271</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">1,155</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">10.0%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">&#8212;%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">12,482</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">10,432</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">19.7%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other revenues</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">159</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">44</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">261.4%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">480</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">339</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">41.6%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">16</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">14</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">14.3%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">&#8212;%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">656</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">397</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">65.2%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of Sales</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1,957)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1,744)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">12.2%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1,339)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1,017)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">31.7%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(468)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(422)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">10.9%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(67)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(55)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">21.8%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(3,831)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(3,238)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">18.3%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">As % of net sales</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(24.8)%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(25.4)%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(40.4)%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(42.0)%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(36.8)%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(36.5)%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(30.7)%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(31.0)%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Profit</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">6,098</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">5,155</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">18.3%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2,456</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">1,744</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">40.8%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">819</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">747</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">9.6%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(66)</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(55)</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">20.0%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">9,307</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">7,591</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">22.6%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">As % of net sales</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">77.2%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">75.2%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">74.1%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">72.0%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">64.4%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">64.7%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">74.6%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">72.8%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Research and development expenses</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1,297)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1,105)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">17.4%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(260)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(186)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">39.8%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(50)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(35)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">42.9%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(129)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(118)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">9.3%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1,736)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1,444)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">20.2%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">As % of net sales</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(16.4)%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(16.1)%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(7.8)%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(7.7)%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(3.9)%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(3.0)%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(13.9)%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(13.8)%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Selling and general expenses</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1,498)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1,280)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">17.0%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(231)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(198)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">16.7%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(359)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(327)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">9.8%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(556)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(461)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">20.6%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(2,644)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(2,266)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">16.7%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">As % of net sales</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(19.0)%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(18.7)%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(7.0)%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(8.2)%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(28.2)%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(28.3)%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(21.2)%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(21.7)%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current operating income&#47;expenses</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(408)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(331)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">2</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">77</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(44)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(40)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(450)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(291)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share of profit&#47;loss of associates* and joint ventures</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">6</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(5)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">20</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(3)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">27</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(5)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income attributable to non controlling interests</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(5)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(27)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(6)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(29)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Business operating income</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2,896</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2,407</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">20.3%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">1,987</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">1,359</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">46.2%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">410</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">464</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">-11.6%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(795)</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(674)</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">18.0%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">4,498</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">3,556</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">26.5%</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">As % of net sales</font></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">36.7%</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">35.1%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">59.9%</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">56.1%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">32.3%</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">40.2%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">36.0%</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">34.1%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Financial income and expenses</font></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(51)</font></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(85)</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income tax expenses</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(841)</font></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(735)</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Tax rate**</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">19.0%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">21.0%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Business net income</font></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="9" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">3,606</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2,736</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">31.8%</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">As % of net sales</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">28.9%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">26.2%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Business earnings &#47; share(in euros)***</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2.88</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2.18</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">32.1%</font></td></tr></table></div><div style="margin-bottom:3pt;margin-top:1pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">* Net of tax.&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">** Determined on the basis of Business income before tax, associates, and non-controlling interests.</font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">*** Based on an average number of shares outstanding of 1,253.5 million in the third quarter of 2022 and 1,254.5 million in the third quarter of 2021.</font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:9pt;text-indent:-9.01pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%;padding-left:2pt">Other includes the cost of global support functions (Finance, Human Resources, Information Solution &#38; Technologies, Sanofi Business Services, etc&#8230;).</font></div><div style="padding-left:9pt;text-indent:-9.01pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%;padding-left:2pt">Includes the impacts of the IFRIC final agenda decision of April 2021 on the attribution of benefits to periods of service.</font></div><div style="text-indent:8.99pt"><font><br></font></div><div style="text-indent:8.99pt"><font><br></font></div><div style="text-indent:8.99pt"><font><br></font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  20                   </font></div></div></div><div id="i410bda0d322d42a2b8a6ead5105a1298_112"></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Appendix 2&#58; Business net income statement</font></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify;text-indent:4.49pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.419%"><tr><td style="width:1.0%"></td><td style="width:14.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.532%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9 months 2022</font></td><td colspan="9" style="background-color:#23004c;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pharmaceuticals</font></td><td colspan="9" style="background-color:#23004c;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Vaccines</font></td><td colspan="9" style="background-color:#23004c;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consumer Healthcare</font></td><td colspan="9" style="background-color:#23004c;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Other</font><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</font></div></td><td colspan="9" style="background-color:#23004c;border-left:1pt solid #ffffff;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Group</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8364; million</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">9M 2022</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:120%">9M 2021 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(2)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">Change</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">9M 2022</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:120%">9M 2021 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(2)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">Change</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">9M 2022</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:120%">9M 2021 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(2)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">Change</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">9M 2022</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:120%">9M 2021 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(2)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">Change</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">9M 2022</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:120%">9M 2021 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(2)</font></div></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">Change</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net sales</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">22,895</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">20,051</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">14.2%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">5,513</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">4,359</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">26.5%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">3,864</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">3,357</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">15.1%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">&#8212;%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">32,272</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">27,767</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">16.2%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other revenues</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">425</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">152</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">179.6%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,187</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">800</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">48.4%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">46</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">41</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">12.2%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">3</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">&#8212;%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">1,661</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">993</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">67.3%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of Sales</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(5,496)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(5,148)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">6.8%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(2,917)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(2,271)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">28.4%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1,358)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1,175)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">15.6%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(187)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(186)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">0.5%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(9,958)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(8,780)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">13.4%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">As % of net sales</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(24.0)%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(25.7)%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(52.9)%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(52.1)%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(35.1)%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(35.0)%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(30.9)%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(31.6)%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Profit</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">17,824</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">15,055</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">18.4%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">3,783</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2,888</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">31.0%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2,552</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2,223</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">14.8%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(184)</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(186)</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">-1.1%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">23,975</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">19,980</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">20.0%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">As % of net sales</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">77.9%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">75.1%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">68.6%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">66.3%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">66.0%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">66.2%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">74.3%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">72.0%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Research and development expenses</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(3,739)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(3,145)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">18.9%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(672)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(502)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">33.9%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(131)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(104)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">26.0%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(341)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(356)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">-4.2%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(4,883)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(4,107)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">18.9%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">As % of net sales</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(16.3)%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(15.7)%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(12.2)%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(11.5)%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(3.4)%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(3.1)%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(15.1)%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(14.8)%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Selling and general expenses</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(4,246)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(3,761)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">12.9%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(598)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(557)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">7.4%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1,111)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1,027)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">8.2%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1,642)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1,452)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">13.1%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(7,597)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(6,797)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">11.8%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">As % of net sales</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(18.5)%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(18.8)%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(10.8)%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(12.8)%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(28.8)%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(30.6)%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(23.5)%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">(24.5)%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current operating income&#47;expenses</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1,294)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(796)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">11</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">123</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">113</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">100</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(68)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(17)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1,238)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(590)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share of profit&#47;loss of associates* and joint ventures </font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">28</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">8</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">45</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">5</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">9</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">8</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">82</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">21</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income attributable to non controlling interests</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(20)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(43)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(3)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(5)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(23)</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(49)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Business operating income</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> </font></div></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">8,553</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">7,318</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">16.9%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2,569</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">1,956</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">31.3%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">1,429</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">1,195</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">19.6%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(2,235)</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">(2,011)</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">11.1%</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">10,316</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">8,458</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">22.0%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">As % of net sales</font></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">37.4%</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">36.5%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">46.6%</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">44.9%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">37.0%</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">35.6%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">32.0%</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">30.5%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Financial income and expenses</font></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(206)</font></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(245)</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income tax expenses</font></td><td colspan="9" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1,910)</font></td><td colspan="3" style="background-color:#f2f2f2;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(1,730)</font></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Tax rate**</font></td><td colspan="9" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">19.0%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:100%">21.0%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Business net income</font></td><td colspan="9" style="background-color:#f4f2f6;padding:0 1pt"></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">8,200</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">6,483</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">26.5%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">As % of net sales</font></td><td colspan="9" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">25.4%</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">23.3%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Business earnings &#47; share(in euros)***</font></td><td colspan="3" style="background-color:#f4f2f6;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">6.55</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-weight:700;line-height:100%">5.18</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6pt;font-style:italic;font-weight:700;line-height:100%">26.4%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:1pt;text-indent:4.49pt"><font><br></font></div><div style="margin-bottom:3pt;margin-top:1pt;text-indent:4.49pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">    </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">    * Net of tax.&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">** Determined on the basis of Business income before tax, associates, and non-controlling interests.</font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">*** Based on an average number of shares outstanding of 1,251.2 million in the nine first months of 2022 and 1,251.7 million in the  nine first months of 2021.</font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:9pt;text-indent:-9.01pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%;padding-left:2pt">Other includes the cost of global support functions (Finance, Human Resources, Information Solution &#38; Technologies, Sanofi Business Services, etc&#8230;).</font></div><div style="padding-left:9pt;text-indent:-9.01pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:4.55pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(2)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%;padding-left:2pt">Includes the impacts of the IFRIC final agenda decision of April 2021 on the attribution of benefits to periods of service.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  21                   </font></div></div></div><div id="i410bda0d322d42a2b8a6ead5105a1298_115"></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">Appendix 3&#58; Consolidated income statements</font></div><div style="margin-bottom:1pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.977%"><tr><td style="width:1.0%"></td><td style="width:54.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.073%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.073%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.073%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.074%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8364; million</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Q3 2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Q3 2021 </font><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9M 2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9M 2021 </font><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net sales</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12,482</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10,432</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:100%">32,272</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">27,767</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other revenues</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">656&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">397&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,661&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">993&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,831)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,239)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,961)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,780)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross profit</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9,307</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">7,590</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">23,972</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">19,980</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development expenses</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,736)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,444)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,883)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,107)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling and general expenses</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,644)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,266)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,597)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,797)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other operating income</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">983&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">258&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,399&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">667&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other operating expenses</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(803)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(548)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,007)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,257)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of intangible assets</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(460)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(385)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,370)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,160)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:10pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Impairment of intangible assets</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,586)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,673)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(177)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value remeasurement of contingent consideration</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring costs and similar items</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(374)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(175)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,166)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(518)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:10pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other gains and losses, and litigation</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(137)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating income</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,724</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,032</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6,553</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6,628</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financial expenses</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(103)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(87)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(292)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(275)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financial income</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income before tax and associates and joint ventures</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,673</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,947</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6,347</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6,383</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(601)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(606)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,096)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,284)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share of profit&#47;(loss) of associates and joint ventures</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,079</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,336</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5,316</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5,120</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to non-controlling interests</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income attributable to equity holders of Sanofi</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,076</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,310</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5,260</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5,074</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average number of shares outstanding (million)</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,253.5&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,254.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,251.2&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,251.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;border-top:2pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">IFRS Earnings per share (in euros)</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;border-top:2pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1.66</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;border-top:2pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;border-top:2pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1.84</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;border-top:2pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;border-top:2pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4.20</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;border-top:2pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;border-top:2pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4.05</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;border-top:2pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:3.9pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(1)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%;padding-left:11.99pt">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service.</font></div><div style="margin-bottom:6pt"><font><br></font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  22                   </font></div></div></div><div id="i410bda0d322d42a2b8a6ead5105a1298_118"></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">Appendix 4&#58; Reconciliation of Net income attributable to equity holders of Sanofi to Business net income</font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.977%"><tr><td style="width:1.0%"></td><td style="width:52.531%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.492%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.492%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.933%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.052%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8364; million</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Q3 2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Q3 2021 </font><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:120%">9M 2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:120%">9M 2021 </font><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income attributable to equity holders of Sanofi</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,076</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,310</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5,260</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5,074</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Amortization of intangible assets </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">460&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">385&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,370&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,160&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Impairment of intangible assets </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,586&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,673&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">177&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair value remeasurement of contingent consideration</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Expenses arising from the impact of acquisitions on inventories</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income resulting from upfront in connection with Libtayo license-out </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(630)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(630)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restructuring costs and similar items</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">374&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">175&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,166&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">518&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Other gains and losses, and litigation </font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">137&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tax effect of the items listed above&#58;</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(241)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(130)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(814)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(446)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Amortization and impairment of intangible assets</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(410)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(90)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(628)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(320)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Fair value remeasurement of contingent consideration</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">7&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(1)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(11)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">2&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Restructuring costs and similar items</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(2)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(37)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(201)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(121)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Other tax effects</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">164&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(2)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">26&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(7)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other items</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Business net income</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,606</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,736</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8,200</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6,483</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:120%">IFRS earnings per share </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(5) </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(in euros)</font></div></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1.66</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1.84</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4.20</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4.05</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%;padding-left:7.21pt"> Includes the impacts of the IFRIC final agenda decisions of March 2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April 2021 on the attribution of benefits to periods of service.</font></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%;padding-left:7.21pt">Of which related to amortization expense generated by the remeasurement of intangible assets as part of business combinations&#58; &#8364;435 million in the third quarter of 2022 and &#8364;363 million in the third quarter of 2021.</font></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%;padding-left:7.21pt">In Q3 2022, impairment of &#8364;1,586 million related to SAR&#8217;245 Non-alpha IL2.</font></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(4)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%;padding-left:7.21pt">In Q3 2022, upfront payment of $900 million net of the carrying value of Libtayo intangible assets, net amount of &#8364; 630 million reported in Other Operating Income.</font></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(5)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%;padding-left:7.21pt">Q3&#58; based on an average number of shares outstanding of 1,253.5 million in the third quarter of 2022 and 1,254.5 million in the third quarter of 2021.</font></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;9M&#58; based on an average number of shares outstanding of 1,251.2 million in the nine first months of 2022 and 1,251.7 million in the  nine first  months of 2021.</font></div><div style="margin-top:3pt;text-indent:36pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="margin-top:3pt"><font><br></font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  23                   </font></div></div></div><div id="i410bda0d322d42a2b8a6ead5105a1298_121"></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">Appendix 5&#58; Change in net debt</font></div><div style="margin-bottom:1pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.419%"><tr><td style="width:1.0%"></td><td style="width:68.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.944%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.944%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.471%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8364; million</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9M 2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;9M 2021</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Business net income</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8,200</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6,483</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation &#38; amortization &#38; impairment of property, plant and equipment and software</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,204&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,102&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other items</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(628)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">118&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating cash flow</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8,776</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">7,703</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in Working Capital</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(999)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">218&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions of property, plant and equipment and software</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,100)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(953)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Free cash flow before restructuring, acquisitions and disposals</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6,677</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">6,968</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Acquisitions of intangibles assets, investments and other long-term financial assets </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(544)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,093)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring costs and similar items paid</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(872)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(781)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Proceeds from disposals of property, plant and equipment, intangible assets and other non-current assets net of taxes</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#160;(2)</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">676&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">461&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Free cash flow</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5,937</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5,555</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Acquisitions of investments in consolidated undertakings including</font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%">assumed debt </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,192)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,385)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Proceeds from disposals of assets net of taxes </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of Sanofi shares</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">176&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">175&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition of treasury shares</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(360)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(140)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividends paid to shareholders of Sanofi</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,168)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,008)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other items</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (4)</font></div></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">741&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">166&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in net debt</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,235</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(1,637)</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#f4f2f6;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;border-top:2pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Beginning of period</font></td><td colspan="2" style="background-color:#f4f2f6;border-top:2pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9,983</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-top:2pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;border-top:2pt solid #ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8,790</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-top:2pt solid #ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#f4f2f6;border-top:2pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Closing of net debt</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8,748</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10,427</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:0.5pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%;padding-left:7.21pt">Includes the impacts of the IFRIC final agenda decisions of March&#160;2021 on the costs of configuring or customising application software used in a Software as a Service (SaaS) arrangement and of April&#160;2021 on the attribution of benefits to periods of service.</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%;padding-left:7.21pt">Free cash flow includes investments and divestments not exceeding a cap of &#8364;500 million per transaction (inclusive of all payments related to the transaction).</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%;padding-left:7.21pt">Includes transactions that are above a cap of &#8364;500 million per transaction (inclusive of all payments related to the transaction).</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(4)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%;padding-left:7.21pt">In 2022, includes upfront payment of $900 million received in July as part of Libtayo license-out.</font></div><div style="margin-bottom:3pt;margin-top:3pt"><font><br></font></div><div><font><br></font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  24                   </font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:3pt;margin-top:3pt"><font><br></font></div><div id="i410bda0d322d42a2b8a6ead5105a1298_133"></div><div style="margin-bottom:6pt"><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">Appendix 6&#58; Currency sensitivity</font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">2022 business EPS currency sensitivity</font></div><div style="margin-bottom:1pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.698%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Currency</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Variation</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Business EPS Sensitivity</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. Dollar</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">+0.05 USD&#47;EUR</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;-EUR 0.15</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Japanese Yen</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">+5 JPY&#47;EUR</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-EUR 0.02</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chinese Yuan</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">+0.2 CNY&#47;EUR</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-EUR 0.02</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Brazilian Real</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">+0.4 BRL&#47;EUR</font></td><td colspan="3" style="background-color:#f4f2f6;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">-EUR 0.01</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #525ca3;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Russian Ruble</font></td><td colspan="3" style="border-bottom:0.5pt solid #525ca3;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">+10 RUB&#47;EUR</font></td><td colspan="3" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;-EUR 0.02</font></td></tr></table></div><div style="margin-bottom:6pt;margin-top:4pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Currency exposure on Q3 2022 sales</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:1pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.977%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Currency</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Q3 2022</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">US $</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">49.4&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Euro &#8364;</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">18.0&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chinese Yuan</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">6.2&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Japanese Yen</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">2.9&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mexican pesos</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">1.8&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Brazilian Real</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">1.7&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canadian $</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">1.5&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Russian ruble</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">1.3&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">British Pound</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">1.2&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australian $</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">1.2&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #525ca3;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Others</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">14.8&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</font></td></tr></table></div><div style="margin-bottom:6pt;margin-top:4pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Currency average rates </font></div><div style="margin-bottom:4pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.977%"><tr><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:0 1pt"></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Q3 2021</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Q3 2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Change</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8364;&#47;$</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.179&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.007&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">-14.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8364;&#47;Yen</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129.790&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">139.332&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">+7.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8364;&#47;Yuan</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.629&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.909&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">-9.4&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8364;&#47;Real</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.163&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.289&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">-14.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #525ca3;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8364;&#47;Ruble</font></td><td colspan="2" style="border-bottom:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86.603&#160;</font></td><td style="border-bottom:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60.008&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-bottom:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">-30.7&#160;</font></td><td style="border-bottom:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:4pt;margin-top:6pt"><font><br></font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  25                   </font></div></div></div><hr style="page-break-after:always"><div style="min-height:50.4pt;width:100%"><div style="margin-top:6pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:4pt;margin-top:6pt"><font><br></font></div><div id="i410bda0d322d42a2b8a6ead5105a1298_136"></div><div style="margin-bottom:3pt;margin-top:6pt"><font style="color:#7a00e6;font-family:'Georgia',serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">Appendix 7&#58; Definitions of non-GAAP financial indicators</font></div><div><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Company sales at constant exchange rates (CER)</font></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When we refer to changes in our net sales &#8220;at constant exchange rates&#8221; (CER), this means that we exclude the effect of changes in exchange rates.</font></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We eliminate the effect of exchange rates by recalculating net sales for the relevant period at the exchange rates used for the previous period.</font></div><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Reconciliation of net sales to Company sales at constant exchange rates for the third quarter and the first nine months of 2022</font></div><div style="margin-bottom:1pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.698%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8364; million</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Q3  2022</font></td><td colspan="3" style="background-color:#23004c;padding:2px 1pt;text-align:right;vertical-align:middle"><font style="color:#ffffff;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9M 2022</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net sales</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12,482</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">32,272</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of exchange rates</font></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,108&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,110&#160;</font></td><td style="background-color:#f4f2f6;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #525ca3;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Company sales at constant exchange rates</font></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">11,374</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:100%">30,162</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td style="background-color:#f4f2f6;border-bottom:0.5pt solid #525ca3;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:7pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Business net income</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sanofi publishes a key non-GAAP indicator. Business net income is defined as net income attributable to equity holders of Sanofi excluding&#58;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.55pt">amortization of intangible assets,</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.55pt">impairment of intangible assets, </font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.55pt">fair value remeasurement of contingent consideration related to business combinations or to disposals,</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.55pt">expenses arising from the impact of acquisitions on inventories</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.55pt">other impacts associated with acquisitions (including impacts of acquisitions on associates and joint ventures),</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.55pt">restructuring costs and similar items</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.55pt">other gains and losses (including gains and losses on disposals of non-current assets</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">),</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.55pt">costs or provisions associated with litigation</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.55pt">tax effects related to the items listed above as well as effects of major tax disputes,</font></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.55pt">net income attributable to non-controlling interests</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">related to the items listed above.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(1) Reported in the line items </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:120%">Restructuring costs</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:120%">and similar items</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:120%">Gains and losses on disposals, and litigation</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">, which are defined in Notes B.19. and B.20. to our consolidated financial statements.</font></div><div style="margin-bottom:6pt;margin-top:12pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Free cash flow </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Free cash flow is a non-GAAP financial indicator which is reviewed by our management, and which we believe provides useful information to measure the net cash generated from the Company&#8217;s operations that is available for strategic investments</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (net of divestments</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), for debt repayment, and for capital return to shareholders. Free Cash Flow is determined from the Business Net Income adjusted for depreciation, amortization and impairment, share of profit&#47;loss in associates and joint ventures net of dividends received, gains &#38; losses on disposals, net change in provisions including pensions and other post-employment benefits, deferred taxes, share-based expense and other non-cash items. It comprises net changes in working capital, capital expenditures and other asset acquisitions</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> net of disposal proceeds</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and payments related to restructuring and similar items. Free cash flow is not defined by IFRS and it is not a substitute measure for the IFRS aggregate net cash flows in operating activities.</font></div><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Amount of the transaction above a cap of &#8364;500 million per transaction (inclusive of all payments related to the transaction).</font></div><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">2 </font><font style="color:#000000;font-family:'Verdana',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Not exceeding a cap of &#8364;500 million per transaction (inclusive of all payments related to the transaction).</font></div><div><font><br></font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">                                                                                                                                         </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">  26                   </font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>chart-6387a406886e4caa9ed.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 chart-6387a406886e4caa9ed.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJ,;7#:M#H7D^4BJV[S([A=K <JRG.,5^ /\ P;R>!_VHOB7\8/B#\'/V6/\
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M/Q=_X(Z?L2?\$"OVL_@A+JW_  42_;V\0>#OBY?ZW<I=:%J/B2WT.PMK??\
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MO_!*7X@? O0_%+;M/\27FHW$[Q0[U1YOLMQ8VYGCC+J9#$Y= >(V)53^<O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M.G_V[I!8#(.T2'3<XZCD$\CGC)_4#X;_ +7W[)GQD\72_#_X0?M0_#KQ7KT
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MZN44 0:9IFFZ)IMOHVC:?!:6=I D-I:6T0CCAB10JHBJ %4   #@ 8J>BB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+XB:/<:E#?Z3<>%KZWB1[!V2Y GEB6-MK*<8;YNV:_"#]JC7-)_82_X.X/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?#)KYGU1X#_X+1_\%%/ I2*3XY)K=NG_ "[:]H5I/GZR"-93_P!]U[S\,/\
M@XZ^,^E&.#XQ?L]>&];0<//X>U&?3GQ_>VR_:%)]AM!]J_-ZBO*Q/#60XI>_
MAX_)<O\ Z38ZZ6:9A2^&H_GK^=S]O/@Y_P %Z_V&OB-Y5GX\NO$/@>[? ?\
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MM([,SM))-)(Q+22R2.[NY.2S'IP*]!HH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBOD[]OW_ (*U? S]BR*X\#:&(_%WC_RL
M)X=L;D"'3V(^5KR49\KU\H R$8R$#!ZZ\%@<7F.(5'#0<I/M^;[+S9C7Q%'#
M4W.J[(^E?B-\3/A]\(?"%WX^^*'C+3M!T:Q3==:EJETL42>@RQY8] HR6/ !
M-?F=^V7_ ,'!4S/=^!OV+/"X506C/C?Q#:Y)[;[:T;IZAYOQB'6O@?\ :B_;
M$_: _;"\:MXS^-_CF:^$;L=.T>W)BL-.4_PP0 X7C +'+M@;F8\UYA7ZSDG
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M]C7DW]K?\%2_VUOET+2K+]FGP#<_\ONIQIJ?BZ]A/]V'B*QW#((;$L9P06H
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !3+FYM[*VDO+RX2*
M&)"\LLC!510,EB3P !SFGU\@_MR?M/MKUY/\%O &I?Z#;OMUZ]@?_CXD!_X]
MU(_@4_>]6&.BG(!0_:F^+_P0_;0T77_V6/'NIZAHOA/5?+32O&&GW3HT-]$Q
M:.::+(66V+;?D?C W':=KQ_D#^U3^RI\6_V0/BI<_"OXLZ0J2A?.TK5;7+6F
MJVI/R7$#X^9#W'WE.58 C%?>==G(_P )_P!H[X5_\,Q_M3P/+H6XMX6\51*#
M>^&KHC"R1L>3"> R'C'!& -OUW"W$]3(ZOLJNM&3U75/NOU77U/&S;*HX^'/
M#2:V\_)GY(45ZI^UW^R#\6/V-?BB_P .OB79I/:W*&X\/>(;(%K/6+3(VS0O
MTS@C<F<H2,Y!5F\KK]QH5Z.*HQJTI*49*Z:ZGP=2G.E-PFK-!1116I 4444
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M:33?A?X,R7?4;_ !N)40[_LT.]&?&"[-'$"&D!'V+7\[/[=W[,/_  7<O?\
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MZ\^E^,+Z\D^VZ5/9Z=97%E!&=X"^9/,=V1F7SRK;@% _4S_@TT^(7Q$\>_\
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M,@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4*CWV?JOZN%%%%>(=X4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M1AY7B_O3[/LT?G^)PU;"UG3J*S04445VF 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 >Q?\ !/[XZ']G']L?P!\5Y[OR;&TU^.UU
M=R>!97(-O<$COMCE9@/517]&5?RUU_2#^Q#\7W^/7[(WP\^+%Q<F:ZU7PM:_
MVC*3G==Q+Y-P?^_T<E?EGB/@E>ABTN\7^:_]N/K>&:^E2B_5?D_T/4Z***_+
MCZL**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MG3?B/HOC6&'$>J:6UO(P'!EA?.3[[9$'_ : /G&BBB@ HHHH **** "BBB@
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MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^/?\ @O\
M_P#*&G]H3_L0I/\ T?#7V%7Q[_P7_P#^4-/[0G_8A2?^CX: /PY_X-TO^"1/
M_!.7_@HW^SC\3OB%^VWXDU/2M2\,^*H++2;RQ\91Z6(;5K42NY612K8;/S$$
M 5R?_!$JWUC]FO\ X..]/^ _[#/Q>U+Q9\/O^$ZUW0;K5[6X62WU_P -0173
M>?<&("*956))5E "-(B.F-RBN9_X) ?\$'=/_P""LW[#_P 9OC)X&^)NJ:5\
M3/ VJQV7@C1', TO5)3;+<>3<LR;T,GS1K(KA4+*S!@"#]$_\&E_[9'P!_8\
M_:[\8?L-_M._!G2O"/Q+\8ZJVE^'_'6K69AU*&_A<1R^';EI3^X5Y(PT:J$W
M3H4?>S0A0#]5O^"QW_!>7X7?\$MO$GAGX >!/A#J/Q3^,WC6.*30/ >DW1A6
M&*:4P023R)'(Y>64,D4$:,\A1LE!M+?)7Q$_X.5O^"FG[!_CKPI>?\%3/^"3
M:^"? _BZX*66J>'M9<7:1KM,I3>\T,LR*P;[.[0.1W7K7PS_ ,'&WACQM\-?
M^#BV+X@_$CXN:_\ #3P_X@F\(ZCX:^(^CVLLUSX?T^*UM;2;4;58W1G>WNK>
MZEVQNK;EX()%?1?[37_!(OX'?M ?!*S\8_M8?\'7T/CKP-I\G]IZ8_BW4H-5
MMDF\LKYD$4FNN6F*.5"HID._:!DXH _2C_@J+_P7?_9=_P"";?[)W@3]I:ST
MBY^(5S\6;!;WX7:#I-V+5-8M3!#.UW+.Z-]G@6.XM\G8[[IT4(?F*_&-C_P<
M*_\ !<?3/ %E^TAXD_X(7:E??#.^L4U*WN])&J"X;3W42)<&012E(S&=WFM;
MA-I#=.N5^WO^P#_P36_:C_X)M_LA_LI>)?\ @I/HW@[Q3I7@"YO/@3\2?&^A
M2:7IOBG2W2S\^&XBGD46K.#8F-'E\U2IVI)EE'PM^T3XJ_X+6_\ ! JR\%GP
MO_P5-\.^+?"EY.;7PQH?A/XD?\)%8P00HK"-M,U"+]Q!LPN8D\M2<!P2I(!]
M'?\ !VA^VQ\8?VA?V5O@'X8A_9:U?2/AOXPT/P[\1;7XB3332VL&KWVGZDIT
M R>2L+S1V[B8D.'(Y\L#FOH'_@V__P""C?[=WB7X=? ?]B/Q!_P3)\6:5\(H
M/#-];P_'F:.^_LZ6*"WN[F&4%K008EG1+<?OL;G&"3\M>8_\'*?Q]\:_M=?\
M&^?[,'[4GC?P4FB:IXS\:Z%JVKZ?:Q,L$$]QH.IL3&&)98G(+Q@DG8R\GJ?N
M_P#X-W_VG?V<?$/_  2H_9]^$6D?'CP?-XM'AFXT[_A%%\26PU,W5O-<RS0B
MU+^:72*-Y2-N?+&_[OS4 ??]?E7_ ,%3O^#E>#]DK]JU/V /V'?V8[OXT?%Q
M+R&QU.WBN)1:6=_*H9+&**W1YKVX"L#(JF-8R=I9F#JGZJ5_,#^P_P",?"7[
M&G_!VAXUU;]LC7[/PXLWQ4\:I!X@\1SK!;P2ZFE[)87+2R8$:3Q7$2HY(&+E
M<D D@ ^V_@K_ ,'4'QQ^"O[4FC_LP?\ !8#]@>[^"KZ\UN8O$EL]U"NGPS,8
MX[J:UNE)EM=X8-/%*=FQ_D<J0/"/^#S7]JO]H37]:\(?LDZA\!]7TKX8:9J]
MOK^D_$8M/]@\1:@UE(C6J9B$3/;K-(?ED8_O.0*XO_@\J^/WP#_:#_:1^!WP
MS^ ?CC1?%_BC0/#^JKKY\+WL=\8Q>7%H+*U9H"P,I,,["+.X"93C$BY]0_X.
MV/"?B_P%_P $R_V1O OQ!D9M?T7R[#7&=]Q-Y#HMM',2>Y\Q6YH ]>_X->O#
M'A[Q3:>'-8U[_@CA#\)+GPI\++2X\._M W6G78G\<2W*QQ3S)<36\:NMPCM.
M%62155@%^4 U^LO[4/Q-^(/P7_9R\<?%OX3_  JO/'/B;PWX7O=1T'P;IXD,
M^M7<,+/%:1^6COND8!!M5CD\ ]*\H_X(X?\ *)W]F[_LB7AK_P!-L%?25 '\
M@O\ P3'_ &UOVM/V?O\ @L'X\_:@^"7["OB'XC_$36;SQ.^J_"?2TNS>::UW
M>&2Y5Q%;R2_Z._[MLQCGKM/%?=O_  =%_'3XQ?M+?\$COV:/CA\?O@!J7PM\
M7Z_\0=2DUKP%JZS"YTATANHD1Q-%%)EXXTD&Y%XD'48)\8_X(J_%/X;? O\
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M_/RUTO\ P<SV=GJ/_!Q%\'=/U"UCGMY]$\%QSP31ADD1M:N@RLIX(()!!ZT
M?HI_P2Z_X.5?#/\ P5/_ ."A&H?LD?"O]EZ\\-^$8/#.H:MIOBS7/$2OJ%V+
M9XE7S+..+RX-XE^Z)I-NWJ<X'YW?\&2?_)\OQ>_[).G_ *<[6OZ3;/1=&TZ*
MW@T_2;6!+.,QVB0P*H@0XRJ #Y1P.!Z5_-E_P9)_\GR_%[_LDZ?^G.UH ^RO
M^"AO_!TYXG^%'[9-]^PK_P $X/V1)?C+XOT76)=(U/4&>ZG6\U*$L)[.QL[-
M#-<>45=6EW*-T;[490)&_+;]NS]JG]H3]L+_ (+F?!3XK_M1?LDZY\%O&4'B
M'P5INI>#=>6<.PAU52MW%Y\,3^5('^7A@-I =L9KO/\ @VP^-7P8_8L_X+6?
M$.T_;H\=Z-X/U=_#?B+PY!KWC&]CM(+37UU2U:9))YR$@=X[>[0.[#);9G,@
M!UO^"V/Q\^"/[1?_  <@?"7QM\ OBSX>\::+9ZWX&TZ?6?"^K17UH+J/5 9(
MEFA9D=EWKG:3@G!Y!  /Z@Z*** "BBB@ HHHH **** "LKQSXZ\&_#+PAJ/C
M_P"(7B:RT;1=)M6N-2U34;A8H;>)>K,S<#T]22 .37-?M&?M)?!S]E/X77OQ
M>^-_B^'2=(L_DC!^:>\G()2W@C'S2RM@X4>A)PH)'S!X&_9Z^-__  4J\7Z=
M\>?VX_#=WX5^%6G72WG@+X&S2$27Y',=_K>,;V(Y6V/"@X8 ;Q* 4)K[XW?\
M%@-3>QT2;6_A[^S)%.5N+\!K76?B,%;!2/.&MM/.,$_>D''))6'[-^''PV\!
M_"#P/IOPU^&/A.RT/0='MA!INEZ?"(XH$'H!U)))+')8DDDDDUK65E9Z;9Q:
M=IUI%;V]O$L<$$,81(T48554<     < "I: "O%OV\_ G_"7_ :YUFWAW7.@
MWD=ZFT<F,GRY!]-K[C_N5[3537M$T[Q)H=YX=U> 2VM_:R6]S&?XHW4JP_(F
M@#\LJ*UO'?A'4? 7C/5/!>J@^?IE]);NV,;]K$!A[$8(]B*R: "BBB@ HHHH
M **** "BBB@ HHHH **** "BB@ DX H ]?\ V5K"Q\'KXB_:)\0VJR6?@W36
M.G1R@[9]1F!CA3ITY.?[I=3VKQO5-3O]:U.XUC5;IY[J[G>:YGD.6DD9BS,?
M<DDU[+^T1(/A/\)/"?[.MIB.]:+^WO%8'7[7,,11-@]43((/7$9KQ.OWCP[R
MCZCD[Q4U[]9W_P"W5HOOU?HT?*YQB/:XCV:VC^?4****_0#R0HHHH **** "
MBBB@#T@^-_A-^T/\.$_9Y_;-\.R:[X>4%=$\3P_\A/0)" !+%+@L5&!D8.0-
MK+(OR5\&_MQ?\$ZOBS^QIJ,'BA;N/Q5\/M7D_P"*?\<Z3'FWE#<K%. 3Y$N.
M@)*O@[&;:P7ZJKOOA'\=]1^'VG7G@3Q9H-IXG\%ZPABUSPIJ\:RV]Q&WWBH<
M$*WX$' R. 1\WBLJQ&"J/$9<M]94WI&7=Q_EE_Y++K9ZFL_98J/+6W6TNJ\G
MW7XKIV/R1HK[G_;2_P""56FIX7O?VE_V$)[KQ)X,4F76_!I+2ZIX>SRP5<EY
MX5Y]9%4 YD7=(/ABM,'CJ&.IN5/1K247I*+[271_GNKH\G$8:KAI\LUZ/H_-
M,****[# **** "BBB@ HHHH ][_X)C? G_AH;]N'P#X'N[/SM.L]775]8!7*
M?9;,?:&5O]EV1(O^V@K^AFOS&_X-T_V=3I_AOQI^U+K=AB74)E\/:#(ZX/DQ
M[9KIQZJSFW4'UA<5^G-?B''>8+&9TZ,7[M)<OS>K_1?(^\X?PWL<#SO>3O\
M+9?Y_,****^*/<"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^TG^U)\.?A[=:M"\NE6WCCQO8:3)>1H0'>);J5#(JEE!*Y )&>M 'HM?)O\
MP42_X(F_\$]O^"GVIVGB[]IKX37"^*K"U%K:^,_#&I-8:F+<$D0R.H:.=%))
M43(^S)V[=S9[/_A[%_P2R_Z26?L__P#AY-#_ /DJO9?!?Q(^'?Q(\#67Q/\
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M,S?\LKA/FC;Z;A@_[+&OS<U/3;[1M1N-(U2U>"YM9WAN(9!AHY%)5E/N""*
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\$_X*H>
M-_&/PT_X)I?'WXA_#SQ3J&AZ]H?P?\17VC:SI5V\%U8W46G3/'-%(A#1NK ,
MK*000"*]WNH%NK62U9B!)&5)';(Q7\^G[;G_  :!_LW_ +*G['7Q2_:9\/\
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M "BBB@ HHHH **** "BBB@ HHHH **** ,/XE_$OP#\'/ FI_$[XH^+++0]
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !7P]_P7\_X*>/\ \$Q_V#->
M\9^!KRZA^(_B^VETCX=31Z7)/#;7C-$DMW)(%,<1@AE:5!)Q)(BKA@6Q]PU^
M<?\ P=#_ +%WQJ_;$_X)C:_<?!OQ;J+2_#N8>*+WP38:9'-_PD20,@<ER#(C
M6]NUU,J1\R-\ISQ0!^)O_!"O]@G]CC_@HU\=+[Q-_P %%_''Q9\0:YXL\2FS
M\-Z3X?\ #^J31:S>.IEN;[4M96"2.- 2?E,J/N5F=@-H?]E?V4_^#:7X$?L
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MO9ZM=:9K]SJ&J1QS1)"SVBZ;]D?[-YRD >5=(3)(<#>A"K]R_P#!E?\  ?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHJGX@\0Z!X3T6Z\2^*=<L],TZRA,
MU[J&H7*0P6\8ZN[N0J*.Y) H ^ _VK/^#8+_ ()%?M7_ !!OOBEJWP7U?P3K
M6JW#3ZI-\/-=;3H+J9CEI#:NDEO&S'.?+C3)))R237HG[ O_  0>_P"":O\
MP3>\=1?%O]G;X,W<OC2""6"V\8>)]<GO[VWBD0QR+$&(AAW(S*6CC5BK$$D'
M%=1XA_X+1_\ !)CPOX@;PQK'_!13X0B\20)(+;QO:3QHV<8:6)VC!!ZY;COB
MO??AE\5OA?\ &KP9:?$;X.?$?0?%GA^_!-CKGAK5X;ZSN .#LFA9D;!ZX/%
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M;Z'_  4MG\"ZX?BN-;35AJ@\2W M?M*VPM@WV;=Y>/* &,8SS7UE10 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M!5%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 5-=T#1/
M$^E3:%XBTFWOK.X3;/:W40=''N#Q7S1\:O\ @GAIUYYNN_!/51:R<L=$U&4F
M,^T<IR5^CY'/W@*^HJ* /R_\:> /&GP[U9M#\;^&;S3+H9Q'=1%0X'=&^ZX]
MU)%>E_#9S\'/V;O$GQ?DS'J_BMSX?\.-T9(3S<S*0<@84J&'1XQZU]R>)_"/
MA?QKI+Z%XMT"TU&SD^];WD"R+GU&>A]QR*\:_:&_8OM?BIX?T31_ 7BA=$@\
M.63V^EZ3/ 9+;YVW,Q?/F*S87+'?G:.,DD^SP_\ V>LXHRQLN6DG=Z-[:I:=
M&[7\CFQ?MGAI*DKR9\(T5Z)\1_V5/CM\+S)/K_@6YN;./KJ&EC[3#C^\2GS(
M/]\+7G9!!P17]+87&83&T_:8>HIQ[II_D?%SIU*4K333\PHHHKI("BBB@ HH
MHH **** "BBB@ HHJUH^B:UXAOTTK0-(NKZZD_U=M9V[2R-]%4$FE*48QNW9
M DV[(JT5[C\,_P!@+XX>-VCO/$]O;^&K)\$R:BV^<K[0H<@^SE*^D?A-^P]\
M$?ADT>HZAI3>(=23!^U:PJO&C>J0CY![;MQ'8U\AFO'&0Y8G%3]I/M#7[Y;?
MBWY'HT,KQ=?5KE7G_EN?(7P<_9:^+_QKDCNO#?A\VFF,?FUC4LQ6^/\ 9.,R
M?\ !]R*^OO@7^Q=\*_@VT.MWT']O:Y'AAJ-_$-D+>L47(3V8[F'8CI7L"(D:
M".- JJ,*H& !Z4M?E.><;YOG*=.+]E3?V8O5_P"*6[]%9>1[V%RS#X;WG[TN
M[_1!1117QIZ(4444 %%%% !1110 4444 ?G=_P '/W[2_P ?/V3_ /@EY=?%
MG]FWXL:UX+\2IX^TBT76M!NS#<""3SO,CW#^%MHR/:OS%_X)\? S_@YW_P""
ME/[-.G?M5? '_@J2;'PWJ>I7=E;V_BCXA:A;W8DMI3%(62&QE4*6'!WG(["O
MT"_X/ _^4/%Y_P!E+T/_ -N*_,C_ ((]_P#!O_\ M8?\%!?V(=&_:6^$O_!2
MK5OAGHNHZUJ-G#X3L["_D2%[><QO)F&]B3YR-W" \\DT ?L]_P $FO@S_P %
M%/V%_P!G'XE>)?\ @KO^U?IWCV>RO6UJQU^UU^[U--*TBVLR]QN,MM$ZX*.^
MU%;('KQ7N?[&O_!1_P#8F_X*"KXC?]CKX]Z?XX'A(V@\1&QT^[@^Q?:O.\C=
M]HACW;_L\V-N<;#G&1GYI^!7[ /Q8_X)N_\ !%WX]_L^_&3]I2[^*NK7/@_Q
MCK">)KV">-TAFT3RUM\3SS-A3"S9W8_>=!SGX(_X,99HO*_:?@\P;RW@M@F>
M2/\ B>C- 'Z\^#/^"J?_  3_ /B'^UM<?L)^#?VD=,OOBS:ZG?:=<>#8],O5
MG2YLXI9KF/S&@$.8XX96)WX.PX).,I\6O^"K'_!/OX%?M.Z;^QG\6?VE=*T7
MXF:O?Z=9:=X5N=-O6EFGOF1;1/-2!HE\PR( 2X W?,1S7X6_L*?\KG_B7_LK
M'Q!_],VK5RO_  7Y^#_AC]H7_@YU\*_ +QM>7UOHOCCQ%X \/ZO<:7,L=S%:
MWK6EM*T+LK*D@21BK%6 8 D'I0!_07\ _P#@IE^P=^U-\?==_9A_9R_:9\/>
M-?&OAO29M3UK3/#IFN88+6*>&WDD%VB&VDVRSQ(525FR_3 )'D_[4W_!P3_P
M2/\ V._B3>_![XR?M;Z>_B?3+@P:KI'AK1;[5VL95.'CFELX9(HY%.0T9?>I
M!!4$5\__ !2_X)#_ +)/_!$#]C+]H3]M?]@2V\9:9\0[?X$:WH]KJFJ>)&N_
ML\<OD2_:D4HH26*2WCE5A@#8>"#Q\3_\&@G_  3Y_8V_:P^'?QG^.'[47P,\
M*_$C6]/UZQT;3;+QKH\.IP:?!)!)-+,D,ZLGFRNP'FD%U\GY2N6R ?M[^QE_
MP4._8O\ ^"@_A"[\;?L??M :-XTM=.9%U2UM5EM[VP+YV>?:7"1SPAMK;6=
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "N0\>? /X-_$PM+XU^'>FWDS_>NUA\J<_\ ;6,J
M_P"M=?16U#$XC"U/:49N,NZ;3^]$RA":M)71\X^,?^":_P +-69Y_!OC#5M'
M=ONQ3JEU$OT!VO\ FYKS+Q-_P3:^,.F,TGAGQ3H>J1C[JO+);RM_P$J5'_?5
M?;=%?4X3CKB7"*WMN=?WDG^.C_$X:F5X*I]FWH?G3KG[&W[2N@%C=?"V[G4=
M&L;F&XS]!&Y/Z5R^I_!?XP:,2-6^%?B.W _BFT2=1^93!K]/J*]ZCXGYG%?O
M:$'Z<R_-LY)9'0?PR?X?\ _*J?PKXGM7V77AR_C;TDLW!_45"FC:O)(8DTJY
M9E^\H@8D?I7ZMT5V+Q3J6UPB_P# _P#[0S_L)?\ /S\/^"?E?9>!_&NHD#3_
M  AJD^>GDZ?(W\EK=TK]GGX[:T1_9_P@\1LIZ/)I$L:G_@3J!7Z9T5C4\4<8
MU^[PT5ZR;_1%1R.GUF_N/S[T#]A/]I77"IG\%P:=&W234-3A7'U5&9A^5>@^
M%?\ @F3XLN&63QM\3=/M%ZO%I=H]P3[;G\O'UP:^PZ*\?%>(O$==6@XP_P ,
M?_DG(Z(9/@X;W?J_\K'P!X\_X)P?M=_!OQ_>?$;X&>*O!/Q7T"6<S+X \?6T
M^E7%NG_/.VN[60)(WH9P$Y.0>_:?#W_@IO\ !?X#3V_P\_:T_9:\4?L]:A-(
M(EN=2T(76A7,OI%J-FA27G.6954=2U?9=5=:T31?$FE3Z%XBTBUO[&ZC,=U9
MWMNLL4R'JK(P(8>Q%?)XO-<RQZMB:TIKLY-K[KV1Z%.A1I?!%+Y&;\/?B;\.
M/BWX;B\8_"SQ[HWB/29_]5J6AZE%=0,?3?&Q&?;.16Y7RU\0O^"1G[+^H^))
M?B-^SW?>)/@MXM?D:[\+-9?3HW.<A9+09@:/.<HJ)N!()K#^U?\ !7K]EK_C
M[LO!G[1_ABWZR6Y3PYXD$8[E3FUEPO8;G<CU-<!J?8-%?+WPU_X*X?LI>(O$
ML?PY^-TFO_!SQ<V _ASXJZ.^E$G."R7+Y@9,_=8NI8$$"OIK2]5TS7-.AU?1
M=1@O+2YC$EO=6LRR1RH>C*RDA@?44 3T444 %%%% !1110 4444 %%%% 'QM
M_P %UO\ @G1\7O\ @J-^PC/^RU\$?&'AO0]<E\6Z=JJWWBJ>XCM!%;^;O7-O
M#*^X[QCY<<')%?E_\&/^#;/_ (.&?V<_ D'PO^ /_!6+P]X+\-VT\DUOH/A?
MXF^)K&TCDD;=(ZQ0V2J&9N2<<FOZ":* /AK_ ()1?\$^_P!O+X!?LT_$[X$_
M\%1OVLV^,\_CJZDM[*^7Q=J>J&TTN:S-O/;B34(HWCW%F.$!'.>M?FE\&?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_!+W2H9?#O@>3P7::#H5S:Q+++ISV;12VEV0=HF=+B"*9\D&4A\L"Y-?1]%
M'X*W?_!O+_P7:\:?LMZ'_P $M_'G[;_P@C_9WT'Q%]NMKFSM[J74O(^TR7 3
MRS9(\FV65Y1 ]P$#$#S2J*!^UO[+7[._@3]DC]G'P1^S)\,_/;0O OAFTT;3
MIKH@S3I!&$,TA  ,DC!I&P -SG  XKO:* "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** /E'_@LS_P4[\-?\$G_ -B;5?VD;KP_!K?B6^U"+1/ N@7,
MA6*^U69)'0S%2&$,<<4LS[<%A&$#*7##\7/V*_!'_!S?_P %QM'U3]JOP/\
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MV\FXU?4+\2;]6>$_ZBU2.9Q;H0"Q9)%"QQQF3]V-=\7^$_"[1IXE\4:=IS3
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@T;7+K1XM,T>.=((7N9[$?:;J[F:2+*%MH8OM"(AK]2?^"='_!).\_X)>_\
M!'CXB?L\IJD.K_$KQGX-UO5/&6IZ=DQ-JLVF/#%:6Y(#-%"JI&K'&]S))A?,
MVC\T/^#(?6M$@_:K^-_AVXGC&I77P^T^YM(R1O:"*^VRD>P::'/^\* .I_X)
MF_\ !6+_ (*9?\$\?^"OD/\ P29_X*:_&Z[^(VDZOXKMO##ZIK6H-?W&GW][
M'&^FWMK>S*L\MO<&>V!CF/RI/N 1D96_H6K^7[_@M$5\=?\ !UOX9\->!7$N
MIK\1_AS8.;<Y(NRFF,!D=PKQY],<]*_INUOQKX-\,W"6?B3Q;IFGRR)O2*^O
MXXF9<D;@&8$C((S[4 ?G-_P<V_\ !5W]H#_@F!^REX3B_9?CM[#QC\2-=N=.
MMO%=W9)<KHMM;PK)+)%'(#&UPYDC5#(K*%$AVDA2/S9@_9M_X+HZO_P2]D_X
M+(:-_P %N?%U];Q>'&\3S^"+/XAZJT,5FLA$D1Q+]E%RG(:V\G:&!CW9&*^W
M/^#OC]K;]F'X3_L7>&_V:/C'\!H_'?BWXA:A=7O@>>74'M%\,RV2(CZH)8QO
M9Q]J6-8>%D#R;SA-K?F#\2_^#=[_ (*@_ ?_ ()B+^UC\+/V@;/6? 7BGX>6
MWC'XE_#+1/$5W9/#8"%+\-+ 2+;4?(B2.5LD,KQXC23:K$ _6?\ X-^/^"Q?
M[07[8O\ P31^*?Q\_;!LEUS6O@F]X;KQ19V26IU^T@TXWNV18U$0N4"LK,BJ
M"KQ$KN+%O@?]FGQK_P %G_\ @K/^Q]^T#_P5>L/^"K/C/X;+\*[K5)]!^&GA
M$W%KI=Z;#3EU*6U"P7$21(L,L42-)'.TC$F1N"Q^SO\ @UI_; ^#W[>/_!.S
MQU^Q#??L\^'/!3?#^TCTCQ-:>$('AM->L-6@N8Q>OYC/(;MQ;SI,S.^2J,"
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
&4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>chart-c3aee8ddf68f4083a75.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 chart-c3aee8ddf68f4083a75.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MJ,EBH!- 'ZW45%8WUEJ=E#J6FWD5Q;7$2RV]Q!('25&&596'# @@@C@@U+0
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M\0?#;PG?OH<OB.P6]6UMT4W,BQ03[H!(S1C$I0NO9@*_FG_X+!?\%=/V4?\
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M_P"P=\!?'MP^F:E=3G3-9TR#^T-5U:Z6***""&VFF'EQ(DA,C,,^:20JQ[F
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M#J>I^)/'GB[Q!I4$\UQ)<2RW5Y/<WEWO=80SR/L+B*-20JJHQ7S1_P $8?\
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M?:1XCE-KXEMYM4@GM82D:M87ME'>VS0O&ZNRNL;%A*0P78"_Z6_\$7/VE_\
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M /!-N?X3^*V^*Q^'%QX AU9([?\ L4Z5*CVOVDR^=YPD6R<IY7E$&0 []I.
M#V'_ (,Z?%7Q(^)'[)_[6_[,GAK5Y8]NGZ;>^&5,Q5+?4=1L=3M7D!Z(3]CM
M.?\ IG[5XW_P1/\ V]/V._V&/^"77[8G[)O[7_B:/PI\1]9AUBTM/"6L:1/]
MKU>232)+!; *(R!(ERLB,CE=GG;CA=Q'WA_P9W?L)?%;]F/]C?QU^T=\7_"%
MYH-W\8=;T^70-.U*W:*XETBPBG$%VR, R+++>7!3(&Y$5QE74G]&OB[_ ,$Y
MOV ?C[\0/^%K_&_]BKX6>+?$I96FU[Q#X$L+NZGVC"^;))$6F  P Y8#M0!^
M"_\ P3F_;5^)?_!*#_@VF\>?$J&2\TWQK\;_ (MZGIOP0MF#"9Q)IUE:7.K0
MKUV0FWN-K %3-%"IXD%>\?L=_MI?";_@W9^ /@'_ ()U^$_V5?&7QJ_:G^)=
MG#XO^(O@OP:F)[.]O(?,M]/EE6.:5I8;5%'DQQ2 ;99B5$HW7_@!HFC_ /!=
M;_@OG<?%O2-)MI?V:/V.XHM.\#V%I;JNFZEJD4A%NT2*-A22YA:X^4;3;V%J
MC ;Q7GO[7OQ0\,?\$MO^#M%OVVOVS8M3TCX7^-=!%QHOC%-(GNXXHG\.1Z8S
M*D*.[F*YB,3I&&=8Y%;;AAD _2/_ ()2?\%U/@M_P4Y^)'BW]G35O@GXJ^$W
MQ;\$027&O?#[Q@ TP@CF6&9HWV1OOAE=$DBDBC=3(N PW%?N>OP(_P"",_B&
M']O[_@YF^.'_  4-_9OTG4Y/A+9:1? ^([C3I+:&[>:VM;*WC*NH99)S%+<K
M&X#A(R6"GBOWWH _D[_X.8?AA^V5X+_X+$VUK^T)\;M)\27WB.WCU/X23V*8
M7P]X;GU[4ETW3Y_]'CS+#(LK-Q+PX_>/T'[(?"CQU_P5*_X(\_L<_'W]L;_@
MKQ^UGX8^-=AH&@:9-\/M(\,DPF*_,TUOY$KG3[;:MQ<7-BFX"3:$=L#&&_.[
M_@\O\%>.O ?_  4>^"W[3=UX2NY?"Y^'%EIMKJ*QD0RW]AK%_=S6WF8PK^5=
MPL ><,3@X-?<'[1O[;7P%_X.4_\ @E_^T1^S!^P!H?B]_%OAGPWH.LK9^)]*
MALA=7@OFO8;"(B=P\K_V;-$2=L8:6,AR,E0#X]_8:\1_\'(__!=GPKXS_:Y^
M$7_!0O3_ (5^&M%U^72M#T2SFETNQGO%A2=K6".T@D<Q1I-"#-.TCDR8RY5M
MOT-_P;I_\%P_VNOVAOVH_%G_  3%_P""C%[#JWC_ ,.Q:A_8/BA[.&WO&NM/
MF\J]TV[6!5CE=0'=)54-B"4.7+*1\M_\&_W_  7M_9C_ ."3/[*7CC]C+]N'
MX>^.]&\1:'XYOM6TR#3/#OF32M+!!%+8312R1M;W"2V[?ZS"D28)4H<W/^#9
M']GWXW?MI_\ !8;XC_\ !6W5OAW>Z!X$36?%&KQ7\\;"WN=7UF:;_0('( G,
M45S,TC+D)LC#8,B@@']'-?R)_P#!5/X@?M(?\%,O^"[6H?"KXM>#=*MM8MO&
M-EX,T?P3_P )JJ:?9V=JP#6RZB8RL/G.9Y7E"$))<-@,% /]=E?R[_\ !R9_
MP1\\6_L%_MAQ_MP_L[? 6'4_@KXANK+4=0L([&6\T_1=5BV"XM;]=Q=;>Z=!
M+YCL%=KB6,$%5R ?N=^R+^PM\$/B/^Q;:_![]J7_ ()P?!#P=ITRRV</@;PI
M]FUVP%B%"Q7'VTV\;/</\SF49D#8;S"^2.KLO^"6?[+>D_\ !.N^_P""7>B)
MXBL_A9>:??6"0Q:N&O[:VNM0EOVBCN'C;(224HI=6;8JABS98_EU\,_^#RW]
MAGX1?LL:!X ^'7[!WCC1_$?ASP[;Z;I'@G3+NPB\/68@B6.*"*]\TSB%0H )
MM2V!W/-?H#^S%_P4[\8Z5_P1ET[_ (*B_MQ_#/5=-OH-$U+7?$WACPQHGDW,
M-H-6N(+6.W@O)8\C[/\ 9RK22#>IW[CN&0#^?C_@H_\ L ? K_@FG_P7.^&/
M[,?[.UWKT_ANW\0>#M21_$FH)<W/G7%_&7RZ1QC;\HP-O'J:_K:K^/[_ (*K
M_P#!5#]GS]N;_@KMX2_;Z^$O@[QEIW@[09?#37FF^(M/M(=3<:?<B6;9'#=2
MQ'<HPF91D]=O6OZ7_P#@EI_P5J_9R_X*X_#/Q-\5?V;_  5XVT33O"NNII.H
MP^-]-L[::29H5F#1BUNKA2FU@,LRG/;O0!U7AC]@S_@G?^S/8>-/BI;?LX?#
MO15UJ_U+Q%X[\6>(-*MYYIWGDDNKN>ZO+O>XA!>1]A<11J2%55&*_G6_X)5?
M"[PQ^V'_ ,',C?%C]@OP.=$^%/A;XF:KXKBGTVR-M9Z=H41E5"(P (([EW2.
M.' VBY"[0J-MQ?\ @N?_ ,'!_P =/^"C7Q&U7]ESP8VI?#OX'Z/X@>TU'1]/
M*RZEX@$$^TW%Z0Z(Z@H7CM%<1A@I=W95=/IW_@DG_P ' G_!)C_@GQX%\/?L
MH_LP?L/?$ZWO_%&LV5KXC\9ZQ>Z:]_K=](ZPK<7+K)PB&0[(4 2-2VT;F9F
M/Z'J^3_^"PW_  55^%7_  2>_94N_C%XGCM]7\9ZV9-/^''@TRGS-9U+:,,P
M4[A;0[E>5QC *H#OD0'YG_X+7_\ !=7]I7]@']MCX6?L+_L;_ KPCX]\8_$#
M2;:XFLO$?VIG6XO;YK.Q@B^SS1A2[Q2EMV>&0\#KUO\ P6#_ ."!NK?\%@_%
M/PQ^(_CC]K0?#S7O 7AN2QO5T'P8U_!=W<KQRR30F2]B>%%D0[5)=L$9;(H
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=M%\4?A7I#77PO\ B!8Z)ILUO?V_V;>+B,I +>Z"OQB6$."<2+FOA;_@W?\
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M%Q:^+?"^GR027EI/&98H/M5G?6\TFS+#9."B[LJ>3C\J_#_[*_P[_P""X?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OS
MQ_X+>_\ !87XW_\ !+_XT_L[_#/X1_#'PIX@M/C%XAU#3]<N/$:W)DLD@N=+
MB5H/)E09(OI"=X891??/L_\ P5UTS_@J/JO[-NB6_P#P22\0Z/IGQ('C>V;6
MI];33FB;1/L=X)E']H1O%N^T&S/ WX!P<;L_ST?\%IM#_P""\FF?&3]GZ/\
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M-%^)8U75M4UW4I]9UO4KB\O+J4R7-W=3-))*Y.2S,Q)8GU/-5Z**^Q225D<
M4444 %%%% !1110 4444 %%%% !1110 5ZG^S5^VE^TE^R7K(U+X*?$J\L+5
MY0]WHER?/T^Z/?S('RN2.-Z[7 Z,*\LHK*M0HXBFZ=6*E%]&KH<92@[Q=F?L
MU^Q=_P %L?@1^T"MKX#^/\-KX#\4S 1">YFSI%^YX^29^;<GGY)3MZ 2,3BO
MJ_Q'\!?@)X\C,WBWX,>$-:2902VH^';6Y$@/0Y=#FOYMJ^L/V#O^"LOQP_8]
MFM? WBEYO%_@)6"G0KVX/GZ<F>6LY6SL Z^4V8SSC86+5^>YWP/%IULOT?\
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MXQU+XB>$_A;X<TOQ!K 8:OKNG:);P7E]N8.WG3(@>7+ ,=Q.2 >HKXR^.?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO2,VW4M9GUF\6XFC1O\ 5Q 11QQKUV1*6RY9C_7O7\=?_!87_@G/\9?V%/\
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MGVT[Q>+K<W5P_P!CF,=S$J*!;.N724?OC\O4'M/^"S?@CXI_\$B_^#B'1/\
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M7Q3I<=I,;E;:*<E%CED!39.G.0<YXXS0!^&?_!,?_@K]_P '+W_!2OQCXS^
MW[-OQX\*^)]:C\-+=W'B#Q7X9T'34\,P^<JFY@\BTC\V9V98@'CG50S'8#AU
MM?L8_P#!;'_@X%^#W[<'BK_@F?XX.A_%SXJ:EJ5YX=T/1_',UG!#H>LPYD:]
M6[MQ$+BV6"*5S$SX<;"A4Y5['_!D=_R>A\9/^R7V_P#Z<8:J?#< ?\'IEQ@?
M\U;U7_TP7% $GQ1_X*W?\%^?^"2G_!2KPA\//^"C/QPL?%&F>()-/U76O"EK
M::=+I>H:)<W3V[M:/;V\;VTJ&&<+C:0\0+B1&^?^E6OYIO\ @\H_Y2J_!S_L
MDFF?^GS4Z_I9H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@#\\?^#B3_@LGJG_!)[]F+2[/X+KIMW\6/B#=SV7A--019HM)MX45
MKG4I(3_K"GF1)&C?*TDH9@RQLC?EW^PE_P $W?\ @N__ ,%:_AE'^U]XO_X*
MT>(_!2>(4DO/#.F:E\1=4^VW4"N5^T"RL9$CL+9G/R8 )!W",*R,T'_!Z-\&
M_&6B_MB> ?CK+\$(=(T#7?#<NE0^-X=56>37KNV$3M'+".;40I,J(&/[W]ZP
M'RDG],?^#:7X2?L_:O\ L6Z'^UK\.?V+/AY\--<U_0;;0CXC\(>*?[6O/$5M
M;1PBXN+P^4GV.5[N.3?;?,RM%DDC:2 :7_!!CX=?\%?_ (!>*/C3^S;_ ,%4
M?B-K7C2Q\*MX>F^&'C'4+O\ M"UU2"X_M(7C6^HR1K/<D>1:;XK@^;#N0E$$
MH+_F9_P7P_X+%_\ !;:.TB\ :K\ O'/[-'@33O'MW!H?CCPS>ZKI5]XG: 3Q
MPI]O5XLP-$6F\E!AB$8EMBU_13H7Q6^&OB?XAZ_\)O#GCG2[[Q+X6L[&Z\2:
M':7BR7.F17GG?96G13F+S1;S%0V"1&3C!!/XZ_\ ![=_R9+\'O\ LJDO_IMN
M* /T!_X(A_$/Q_\ %C_@D[\#/B-\4_'.L>)?$.K^"8Y]6U[Q!J<MY>WLIFE!
MDFGF9GD;  W,2>!7U37Q]_P0#_Y0U_L]_P#8@Q?^CY:^D/'_ .T1^S_\)]=B
M\+_%/XZ>#O#6ISVRW$&G>(/$]I9SR0LS*LBQS2*Q4LCJ& P2I'8T ?)__!<'
MX#_\%2OVE/AA\/\ X0_\$OOC#=> M3U+Q5-_PG7BJ#Q'_926.F"V;8SW$2M<
M@>:5PMLK.3U&T$C\:O\ @IK^P]_P7'_X(I_#?PY^V)J7_!5WQCXLT^]\31:5
M?3Z1\0-9:2UOI8I9HQ-;WCM'=0.() 2V?F"[DP<C^E7XK?%CX9_ SX=ZO\6_
MC%X[TOPSX9T&S:ZUC7-9O%@MK2(?Q.[$ 9)  ZL2  20*_G9_P""A/[5W[4?
M_!TQ^U_HG[$'_!/7P+?6?P2\!ZP+_4?%VMVSPVTDQ#P_VS?$C]S&L;3);6O^
MN</(2NYBD(!^H'["O[2/[4__  6._P""#Y\=>&/B&G@/XR>+_#.J^'T\9Z7=
M3Z<EKJUM<26RZC%):#S("ZHDC>4!L=W50 !7PCX^_P""&O\ P<+?"WP-K/Q,
M^(?_  7\U?2- \/:7<:EK6JWGQK\8+#9VD$;22S.=O"JBLQ]A7[/?L.?L@?#
M']@C]E#P3^R1\(?-DT3P9I M4O+E0)KZX=VFN;N0#@/-/)+*0. 7P. *_(S_
M (/!O^"I4_@?X?Z3_P $M_@CKKMKWC&.#5?B8]BY,EOIH<-9Z=\O(>XE42NO
M#>7%&""L] 'S?_P:]_M(_P#!3#]K/_@JG8+X\_;&^,'Q!^&_@KP[JM_XQM_%
M?Q&U6]TQHY;:6ULB\%S.\;R-<2QNB,-P\IW'^K)'Z0?\%]O^"D'_  51_8_C
MUKX;?L,?L3ZEXC\)W/PIEUCQ!\:;;3;VXC\+2F2^CN2OD[8XY;>W@CN!([D)
MYJLR$#!]/_X-[?\ @E]!_P $QOV!-'\->--#2W^)7CWRO$'Q&E=!YMO</'_H
M^G$]=MK$VPC)'G/.PX>O=O\ @J-_RC,_:*_[(3XN_P#3-=T ?EY_P9M?M7?M
M2?M0:=^T2_[2W[2GC_XB-HD_A,:*?'7C&^U<V F&L>;Y'VJ63RM_E1[MN-WE
MIG.T8_4C]NG_ (*-?LA?\$V_ >C?$O\ ;#^)L_A?1M?U<Z9I5U!H-[J!FNA$
M\I0I:12,OR(QW, .,9S7X\_\&,__ ""_VG/^OCP;_P"@ZW7I_P#P>V_\F._"
M'_LJ[_\ ILN: /J+XM_\'0G_  1G^$MKH%Q+^TO=^(F\0:;#?QP>%_#%Y=26
M,$H#(;H%%\B3!R86_?+_ !(,C/;_ !R_X.!_^"2WP#^!_A;X^>)/VL]*U;2O
M&UB;SPKIGAJSFO=3OH0[1NS6BH)+4*Z2(QN!$ \;I]]2M?F-\9?^"8'[!NC_
M /!J78?M6:#^S3X<LOB8/AOH?B)O'<4+G4WOIM1M4F8SLQ8QO')(AB_U8#?*
MJD*0?\&OG_!,+]@W]LK_ ()<_%7XH_M*_LT>'/%WBB3XBZQH%MX@U>%Y+FQL
MH]&TV:);<[L6[K+<S.)(PKY898A5  /V/_8$_P""E7['O_!3+X:7_P 4/V1?
MB?\ V[:Z->)::]IMY8RVE]I<SJ6C6>"4!@'56*NNY&VN%8E& ]XK^;__ (,A
M]5U&']JSXW:)%=NMI<?#VPGG@#?*\D=]M1B.Y ED _WSZU_2!0 52\1^&_#W
MC'0;SPKXMT*SU/3-0MW@O].U"V6:"YB889'1P5=2."",&KM% 'Q/KO[-/[2?
M_!-W6KKXE?L'65YXY^%<]P]UXD^!.H7K/<:<"=TEQHDS[F4]2;9L[CG =F79
M]&?LM_M=? W]L+P"?'OP6\5?:?LTGDZSHM['Y.H:1<\[K>Z@)W1."&&>5;:2
MK,.:],KYI_:D_P""?$/C[Q\/VG_V4O';?##XRV<9V^(["+-CKZ#!^S:I;@%;
MB-L >9M+KA20^Q5 !]+45\R?LP_\%!IO%7Q#3]EG]L/P(/AC\8H$ ATBZESI
MGB5.@N=+N22LRL03Y18NO(!<J^WE_P#@JI^VI)\'?!Q^ ?PWU8Q^)_$-H3JM
MW;R8?3;%L@@$?=EEY [JFYN"R&NG!X6KC<1&E3W?X+N:T:4JU10B>(?\%0/V
M]9/BKK=U^SS\(M9/_",:;<;->U*VDXU6X0_ZI2.L",.O1V&>552?C&BBOTW!
MX2C@J"I4UHOQ?=GTU&C"A34(A11174:F3XX\%P^.M)6*V7;JMHA%@_:=<DF!
MO0DDE&[,2IX;<GCSH\;E'4JRG!!&"#7N]<G\6/!#Z]!+XUT> ->0H7U:%!\T
MZ#K< =V _P!9CDC]X0<2-7KY=C.1^RF].G^1\GG^5<R>*HK7[2_7_/[^YYG1
M117NGQX4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!U'P8^
M,GQ"^ 'Q,TGXM_"W7Y-.UK1KD36TZ'*N.C12+_'&ZY5E/!!(K][OV(?VR?A]
M^VQ\%;7XF^$62TU.WVV_B70C+NDTV[VY*^K1MRT;_P 2^C*RC^>FO9_V$?VQ
M?%_[%/QZL/B?HOG76CW.+3Q3HR/@7UDS#< #QYJ'YT;LPP3M9@?E^)\@AG&%
MYZ:_>QV??^Z_T[/U9V83$NA.S^%_U<_H1HK'^'WC_P (?%3P/I7Q'\ ZW#J6
MC:U8QW>G7L!^66)QD'U!'0J>0000""*V*_%)1E"3C)6:/?335T%%%%(84444
M %<M\5O@=\%/COH<?ACXX_!_PMXSTV*3?%IWBOP_;:C C<?,([A'4'@<X[5T
M>H7]II=A/J=_+Y<%M"TLS[2=J*"2<#D\ ]*_);XG?\'FG_!+#P7K\FB^!OAS
M\7?&$$<F/[6TOPU96MM(N0-R"[O(ICQD@-&O8<9X /TS^#W[*_[,/[/,DTOP
M!_9Q\!^!GN(_+G;P?X/LM,,B<?*QMHDR.!P?2N\KXP_X)G?\%YO^"?\ _P %
M4O$MW\.?@!XGU[0_&=G8M>R>"_&VEQV=]-;(0'EA:*66&<*2,JDA< [BH&35
M3_@IS_P7N_8N_P""3OQ<T#X+_M+>#_B%J.K>(_#@UNPE\'Z):74"VYN)8-KM
M/=PL'WPN<!2,$<]@ ?5?C;]GSX!_$OQ+!XT^(WP0\(>(-8M8DCM=6UOPU:W=
MS"B,715EEC9U"LS, #@%B1R:^'?^#@+_ ()B_M2_\%7-%^"?[//PAUK1M+^'
MNE?$!M:^*.IZCJABN;>%4CMXI+6$(PGD6"XOR%8J-WEC/S$CR+_B,]_X)0?]
M$O\ CA_X2.F?_+.OT_\ V??C5X2_:3^ W@G]HGP#:WT&A>/?"6G>(M%@U2%8
M[F.TO;:.YA65$9U60)(H8*S '(!(YH U_AYX \'_  H\ :'\+OA[H4.EZ#X;
MTBVTO1--MEQ':VEO$L4,2CT5$51]*TM0T^PU>PGTK5;&&ZM;J%HKFVN(@\<L
M; AD93D,I!((/!!K.^('CKPQ\+_ >M_$SQMJ)L]%\.Z1<ZGJ]VL+R&"UMXFE
ME?8@+-A$8[5!)Q@ FOR?\?\ _!Z!_P $NO"^OOH_@_X2?&/Q-;1OAM5LO#NG
MV\$B_P!Z-;B^24_1D2@#]3?AQ\"_@E\');N?X1?!WPKX5?4%1;]_#?AZVL3<
MA-VP2&%%WA=S8SG&XXZFK_Q#^&?PW^+OA:?P-\5_A_HGB?1+H@W6C^(=)AO;
M6;'3=%,K(V/<5\R?\$SO^"V'["/_  5;&J:-^S-XPU>S\3Z)9B\U7P5XNTU;
M/4X+4LJ?:%6.22*:,.RJS12/L+(&V[UW<]_P4I_X+U?L0?\ !,7XE:3\"_BC
M9^,/&?Q U>TCNHO!7P\T:*]O+:"0D1/.9IH8T+[6*QAFD( ;8%96(!](_!C]
MC[]DG]G'4)]7_9Y_9;^'/@.[NHRES=>#/!%AI<DRDY*LUM$A89[&NU\6^#_"
M7C[P[=>$/'?A;3M:TF]0+>Z7JUC'<V]PH8, \<@*N P!P0>0#VKY7_X)A_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^)YO#^D:+<Q)/JH(-DA\YB%MK8B,I&,\6\2<KFOV)HH *_.'_@LK_P $FO\
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M-^,;?Q;X5ATFWM-#TRX@>W=+E9B[&4X((7&!SFOU(HHH **** "BBB@#PO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M'[^_O=5OI]4U*ZDGN;F9I;B>5BS2.Q)9B3U))))J&BBOT_8^H"BBB@ HHHH
M**** "H-7T;2_$FDRZ#K*L()L,DT8R]O(,[9%!ZXR05XW*2,J<,)Z*J,I0DI
M1=FC.K2IUZ;IS5T]SQ3Q#H.H^&=8FT35(PLT+#E<E74C*NI/52""#Z&J5>R>
M-?",/CC1UL@T:7]JI_LZ>5@H.3DPLQZ*Q)()X5CG*AG->/7-M<6=Q):7<#Q2
MQ.4EBD4JR,#@@@\@@\8KZ?!XJ.)IWZK<_.,SR^IE^(Y'K%[/R_S74911176>
M<%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5]V_\$'_ -J$_"S]
MHJ^_9_\ $>H[-'\?VX^P"1_EBU2!6:/&>!YD?F(>[,(AV%?"5:/A#Q7KW@3Q
M7IGC?PM?O:ZGH^H0WNGW49^:*>)PZ./HR@_A7!F>!IYE@*F&G]I?<^C^3-*-
M1TJJFNA_3/17(_ 3XN:)\>O@MX7^,OATJ+7Q)HEO?+$K9\EW0&2(GU1]R'W4
MUUU?S[4A.E4<)*S3L_5'TZ::N@HHHJ!A7C_C[_@GK^P+\5M>D\5?%']A[X/^
M)-4EE\R74M?^&FE7EP[_ -XR36[,3[YKV"B@#$^'OPS^&_PC\+P>"/A1\/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 > ?\ !3/]FS]IG]K']D[5?@Q^R/\
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MO_%2U^(7Q7^*/BI]5\8^.(;5X_/A!9XX!YA+DF66XF=N-[S<C"*:^?/VGO\
M@@=^W%\-_P#@H7XT_P""BO\ P2 _;>\/_"OQ'\2XKD>,M$\7:(+BW$MU)'+=
MO$QM[E)%EGC6?9)"&CE!*O@@+^LU% 'P3_P1 _X(J?\ #J?1?'?Q&^*WQF'Q
M#^*_Q0OX[CQ=XDAM'BMH8T>67R8?,)DD+RS2222MM+G8-B[,M][444 %%%%
M!1110 4444 -GFAMH7N+B54CC4L[N<!0!DDGL*_#?]H_XJW'QO\ CMXJ^*DT
MC-'K.LS2V8?JEL#L@0_[L2HOX5^N/[='Q)C^%/[)WC;Q69'6232&L+?RI0DG
MF73+;@H2#AAYI8'!QMSCBOQI&FZ#<[1:Z^T#%29/MUJP53_=5H]Y;ZE5K['A
M:BHQJ5GZ+\W^AW8'%X/#5&JLTF]K]O78SJ*T%\+ZW-M^PV8N]R%]MC*L[*OJ
MRH24_P"! 5GD$'!&".H-?7)I['OPJ4ZL;P::\M0HHHIEA1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'Y7_\
M!8S5#J'[745H7S]A\)64 &>F9)Y,?^1/UKY3KZ6_X*U2;_VTM97^YI&GC_R
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M@<CV"SLQ]E]J_)JOT#AZK[3+5'^5M?K^IX>.CRXAON%%%%>X<84444 %%%%
M!1110 4444 %%%% !1110 5]1?LKZ2FF_"&VO%ZW][/<-]0WE?RC%?+M?8OP
MATR/2/A?H%E%'L_XE4,CKC&&=0[?^/,:B703V.CHHHI$!1110 4444 %%%%
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M_#@7$@0ZQXD\.075A'DX&Y["XGF'N?)P/7&37ZO(ZR()$;*L,@CN* %HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^P__ ,'5DW[)OPF\1:B/#&G>+O&WA?;=W&Z6\TJ#3-0N;>*=E $C*]K:N3@
MO$#@=!SG_!5G]I'Q?^US_P '%.M>#?C7^SGXT^.?A#X;^+;GP]X=^!_@V>Z%
MUJ5I86KO)' MO')(!+/&]U.R(6:)67<JJI4 _HG_ &<_^"JO_!.3]K7QLOPU
M_9U_;+\!>*/$4H8VV@V>MI'>W(4$L889=CS8 ).P-@#)XYKUOXM_&;X1? +P
M-=_$WXY?%#P_X/\ #EC@7FN^)]8AL;2(G[JM+,RJ&/0#.2> #7\K?_!0_P#9
M\_:#^//Q6\"?&;_@GC_P;]?M#?LY:WX5+R:E)H7@77)X[NYCEAELKJ!8[",6
MT\+++EUY?=&>"F3]1_\ !V!\(/\ @H)\>OAI^SI^TCJOPR\5WO@.V^%UM-XS
MT:PTJ?;X<\33JLMW)>VZKNMBR-%"K2* C02)E2<, ?L)X(_X+8_\$E/B)XG3
MP=X6_P""A/PM?4)9/+ACO?%,-HDKYP%22X*(Y)X #'/&,YKZA5E90RL"",@@
M]:_E*^&W[8__  ;6_M)>#M-^"W[2/_!,#QA\"[ZXACLT^)/PX\>76L'3)" I
MNY5N&#2(#\Q#P7+#L&/-?U4>&-1T76/#>GZOX;U2&^TZZL8IK"]MY0\=Q"R!
MDD5APRLI!!'!!H O4444 %%%% !7R=_P5W^ I^)G[/47Q1T>SWZIX)N3<2%%
MRSV,NU)Q_P !(CDSV5']:^L:JZWHVE^(]&N_#VN6,=U97]K);WEM*,K+$ZE7
M0CN"I(/UKIPF(EA,3&K'H_\ A_P,ZM-5:;B^I^!M%>@_M2? K5OV</CGKWPI
MU)9&@LKHR:5<R#_CYLW^:&3/0G:0&QT96':O/J_4*=2%6FIQ=T]4?.2BXR:8
M44458@HHHH **** "BBB@ HHHH **** /2?V4](.I?%R&]!_Y!]A/<8]<J(O
M_:M?3]>!_L9:5%+JVO:XP_>06T$"'_9D9V/ZQ+7OE9O=DR"BBB@D**** "BB
MB@ HHHH **** "BBB@ HHHH *ZOX)^ )?B5\2],\,&$M;-,)K\]E@3YGSZ9'
MRCW85RE?5'[%OPQ?PWX.G^(&J6^VZUK"V@8<I;*>#_P-N?<*IKSLTQ:P>#E-
M;O1>K_RW.C"T?;5DNG4]K5510B* H&  . *6BBOS@^D"BBB@#XY_X+^?M,^/
M?V1_^"1/QF^,GPMU:?3_ !$-$M='TK4;5RDMFVHWUO8//&XY21(KF1T8<AU4
MC!K\DO\ @U#_ &#/V,M=_9T^,'_!4']L/P+H_B>W^'6JW5AIL/B'2?[1MM$M
MK'3HM1OK\6I5Q-,8YXPAV,Z>2VP;GK]N?^"GW[&</_!07]@?XF_L@C5(+&\\
M8>']FC7MR#Y4&HV\T=W9O)@$B,7,$.[ )V[L FOYS/\ @EE_P4J\=?\ !!SQ
M[\6/^">O_!2_]D_Q-?\ P_\ ')>+Q?X52!%O[*5H7M99[=)72&]MKFW(1BLJ
MJZQQO'(0"' /O_\ ;8_X*+_\&DG[>_PYN/ /QO\ $^GVEVT)73O%OA3X2:OI
MNLZ8V.'@NHM.R0.OER"2)L#=&V*]R_X.,O\ @N#XP_X)5?!GP=\.OV9K#3[O
MXF?$>VGN-*U35[;SX-"TR$(K79A; EF=Y D2OE 8Y&<-M"-_/_\ \%@_BU_P
M3J_:6_:F\+:O_P $GO@%J/@_P>W@BUL-1\.G03:SW6M_;;QG=84EF+EH9+5
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M]/%^C3VMU]D3491##>0W4*B1'BF($UO*T@V(^S!9'/P9X0_9?_9>_P""3_\
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M8V4LQ#(02<9H ['XD?\ *ZA;_P#96-*_]1^WK^E:OYJ?B1_RNH6__96-*_\
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M?@;X1O\ Q%/\)?"]E<^(=$TJW::X_LR\TJS66[2-06D$+VT6\*"521W/RHQ
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MB'X;ZYXSTKQ+IFI6\9\BX9+6*WO]-:;!2&Z CF>,-U1XV&<,  ?7?PU_9?\
M^#L+]DOXM_#_ .)OCW]LKP[\7/!^I>,])MOB)X5TFYBU">RTR:[B2ZD\N\L(
M"%2-W):UDWKM+8V FN:_X*1?\%:?^"A7P-_X./?AS^P[\*_VC+G2?A9KGC[P
M#I^J>$T\/Z;*D]MJ%Q9I>1^?+;-.OF++(,K("N[Y2N!CV_\ XBX_^"?_ ,1_
M&7@#X3_LT?#?Q[XH\6>/?&>CZ&ECK>E1Z9;:4EY>0P233R^9*7>-9"52)7#L
MN"Z [J^ _P#@KU_RMV?"3_LJ/PN_]*]/H ^F/^#J7_@K!_P4#_X)Z?M(?"[P
M-^QU^T1<^"]*\0>"+F_UBT@T#3;P7%PMXT:N6N[:5EPH PI ]J\&_P""I7[3
M_P#P=._L=>!]!_;M^/WQXT3P'X2UC7+>QL/"?@";3KFWT2>6)YH8+J%H9//#
M+%)EWDG7<,%E!050_P"#W7_D[SX*_P#9-[S_ -.#U]U_\';2JW_!%*V+*"1X
M]\.D9[?NYZ /0_AW_P %SXM"_P"" >B_\%<OC+X,M+GQ-+H<MC)X;L',$.I^
M((]1ETQ%3[QBADFB,[ ;C'$7QN*@'\\_V;_VA_\ @MI_P4^^".K?MG2_\%M?
MA5\%)+R]O4\&?"Z36+#2_.$#,FQT(WP1-(K(CSF>1@I9OE*ENN^!7[%/Q9_;
MM_X,Z/"WPI^!6BSZMXMT3Q!JWB/1M"M1F75#:>(]0,UM&/XI# \S(@R7D1%'
M+"OB'_@EY\4O^#>7P;\&KOX1_P#!7;]B?QDGQ/T'6+N.?Q98:SKZQ:A 9"4A
MGM;34(?LMQ$<PE1#M*HK,V\M0!^H7_!O7_P< _'']KSX'?&3P9^VS''XD\8_
M!?P5/XMMM?TBPAMKG7M*@23SX98H56(7$;K&JNBJ)!.,J&0L_P 7?L[_ /!6
MS_@K;_P61_: \66&@?\ !5WX6?LNZ5I8BG\.^%-;U.WTF.[65Y%2WM)7@::]
MD0(#*9)<C>I2/!(3ZI_X)%?M3_\ !%_PSX__ &C_ (O?\$IO^">?B708?AE\
M!M2U?7-?\5^,]2D/B:")OM!TQ+2ZNKU((Y&M4/GM^\ZCRL9#? OQ>M?^#5W]
MJ7PQJGQ?\)>//CK^SUXNOH9+AO >G^'DUC3(;M@69((PD@,9?A%^U0* 0-L8
MX4 _<3_@C3X._P""R/PW\1_$'P-_P4^^.OAKXH>%8M.TJY^%OCSPQ-92P7V]
MKH7:>9#!!.Y55MCF>,_?^1V&<?>%?S^?\&3>F_M:)K?Q:U746UU?@D^D6\=@
MM^9/L$GB'[0#FS#_ "[Q;^:)S'_>@W\[*_H#H **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "OSR_X.._^"2_Q$_X*L?L
MD>&_#WP!LM)?XD>!O%:W_A]M7O1;136-Q'Y-[;>:00F[%O-[FU [U^AM% 'X
MY?\ !M3_ ,$#OVC?^":'QP^('[2'[96D>'H?$-YX=@T+P3!HFL+?"*"6;SKV
M9V"@1N3!:HN.2K2C@'GV'_@Y3_X(X?&G_@K%\"? FK?LW:_IB>./AEJ6HS:?
MH.LW?V:WU>TODMQ/&LQ!6.=6M("F_"$&0%ER#7Z644 ?@KXV_P"";W_!SK^U
MW_P3,F_8/^.]]\)_"?A#PSH6BZ5HWA3S[)]6\2P6%S:_9H9[RV>6"WCAC@6;
MS%9))&MT0JPD=A]<?\$MO^"+GC?P'_P12\8_\$O_ -OC2[&UF\::WJTMZWAS
M5$N_LD<QMY+6ZBDV[?-BF@25001NC7(()%?IE10!_/S^SI_P2@_X.9/^"-NO
M^*/AM_P3H\9^!?B!X!\0ZE]L,4VH:?'!+,%$:7;6NIO$UK<&-45Q%(Z,%0%I
M-B$?:7[+W_!+C]OW]KC]A#X[_ 3_ (+;_&:WUKQ#\9]5M;G13H.II=?\(FMK
M&C6S0PQ1QVL!CN(TD\J E9 &WL3(QK]-** /Y_/V9_\ @F-_P=#_ /!'\>(?
M@E^P/XE\ ^// &L:N]]")-4TXVRS,JI]K6#4VAEMI61$#I&SH2HY?:&KZHM/
M^"<G_!8#XX?\$8OVB/V>?VVOBIHOC3XY?&+Q-#J>@6[^(P;/2[1&TO%GN6)+
M>T5?LD[B*W4Q?.#DL[5^K=% 'YB?\$7?^"5G[6O[#W_!'WXS_L8?'C2-"M_&
M_C?6/$USH,&F:VES;/'?:%9V4&^4 !"9H7!&.!@]ZYG_ (-A?^"0?[97_!*J
M;XW2?M;:+X?LQX[7PV- _L+7DO=_V(ZIY^_:!LQ]KAQZY/I7ZPT4 ?C%^SQ_
MP1#_ &[?AM_P<B:A_P %./$^@>&4^%ESX^\4:M%=P^(T>]^S7VE7]M;G[/MS
MN,EQ'D9X!)[5<_X+#?\ !O-^U3\3OVX[?_@J3_P2J^,&F>&/B;]MMM2U?0=4
MO/L;'4H(UB6]LIRCQ$RQJJRP3A8W/F,782,E?LC10!^(FM>"/^#S_P#:(\/M
M\&_$WB+X>_#&RO(_LU_XUL=5T:WN7C.0SB6Q-S/ >^Z"*-QQM(YKZ(_X*+?L
M]_\ !P-X'^,WP^^-G_!,'XX^'=9TK1OA-I?AOQOX$\3:W&\6L:O;3W4DM^(;
M^,0@R+-$IG6:*=O*VO\ *!7Z9T4 ?ST_'W_@B#_P71_X+*_M">%?&'_!0[X<
M?!KX,Z3H"R0:CK_A6&Q>]NK:5XVE;9937$EY, @$:SS1QI\^"N]MW[\_##X>
M>'?A'\-/#OPH\()*ND^&-"M-)TM9Y-[BWMH4AC#-@9;8BY/<UNT4 %%%% !1
M110 444CND:&21PJJ,LS'  ]: /DW_@K%^RQ+\8_A%'\8O"&F>;X@\&PO)<I
M$F7NM-/S2K[F,_O![>9CEA7Y;5^G7Q:_;E^*_P"T[XZU+]F/_@F?I=CK5_9R
MFU\9?&'4XO-\/^&0>&2 X*W]UC)5%W(#@G>N\I\@?MW?L6>(_P!DGQAITT>H
M'5= UJT0VVKQVGDI]L5!]HB,8+"++9D1<GY& !8HQK[#AS,$X_59OSC^J_7[
MSRL?0U]I'YG@E%%%?6'F!1110 4444 %%%% !1110 4444 ?2'['^FK;?#J]
MU)HMKW.K. Q'WD6.,#_QXO7K%<7^SSIDFE?!S1()H]KR0R3-[B25W4_]\E:[
M2LR);A1110(**** "BBB@ HHHH **** "BBB@ HHIT$$US,EM;0M))(P6.-%
MRS,3@  =30!U?P3^&%Y\6?'UIX9B#K:*?.U*=?\ EG I&[GU/"CW8>AK[BLK
M.UTZSBT^Q@6*"")8X8D& B*, #V &*X+]G+X.0_"/P0L=_$IUC40LVIR#G8<
M?+$#Z*"?JQ8],5Z%7Y_G./\ KN)M!^Y'1>?=GT&"P_L:5WNPHHHKQSL"BBB@
M KD_BO\  3X%_'G2XM$^.7P7\)^,[*!B8+3Q9X<M=1BC)ZE4N(W S["NLHH
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M9;9Y8E=[:<J7B)&2C;&9<CH=I(R."1S0!PG_  R;^RO_ ,+2/QR_X9H^'_\
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MIS[)J'_"2?9/^$2\SS?L<WV7']G?Z1_Q\>5]SC^]\N:^./@1_P &CW_!6/\
M9YM[[QI\$_\ @IAX:^'7BN_LS!=GP%X@UVQ2YC#K(L,EW!'#(T?F*K8,1 *A
MMI(%3?\ !#/_ (*U?\%+_@9_P5F_X=/?M[_%_5/B+97GB+5?#-[<>(=3.I7N
MC:O9Q3R+/!?/^^N()&M]A65F&V174(596 /I/_@IY_P4W_X*/?'#_@L=H/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MAI\#? 6G_"_X1>"K#P_H&EP^78Z9IT.R-!W8]W=CRSL2S$DL223714 %%%%
M!1110 5X3^VW^PWX(_:X\*"[B:'2O%^G0%=&US9PXY/V><#EXB2<'ED))7.6
M5O=J*UH5ZN&JJI3=FB9PC4CRR6A^$?Q0^%OCSX->-KWX>_$CP[/IFJV$FV:W
MG7AE[.C#AT;J&&017/U^U?[4G[)/PJ_:O\&?\(YX\L/L^HVR,='U^U0?:;%S
MZ$_?C)^]&>#[, P_*;]J#]D3XO?LI>*O[%\?Z3Y^FW,A&E>(+-";6]4<X!_@
MD ZQMR.HR,,?OLLSBCCXJ,M)]N_I_D>)B,+.@[K5'EM%%%>R<@4444 %%%%
M!7;?LZ:9'JOQDT6&:/*122SDXX!2)W4_]]!?QQ7$UZW^QYIK7'Q U'4WBREM
MI#*'_NR/+'C_ ,=5ZF7P@?1M%%%29A1110 4444 %%%% !1110 444^"">ZG
M2VMH7DDD8+'&BDLS$X  '4T ,KG]&\9?&_1_'$ES?_L#_%'Q9X7M;@BWU+PW
M%!LU,#!!3>ZL(R<@L/0@8ZCZJ^ O[(+J\'B_XM6HP,/;:&W/T,W_ ,1_WUW6
MOHB...&-888U1$4!548  Z "OE<VSM1_=8:6O5K\E_F>KA,#?WZJ^1\C6/\
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M]C#X3^'=;AE\V'6-"^'6F6EU')Q\XEB@5PW Y!SP*^1_^">7_!S5_P $Y_\
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M6+!B4D#K)\I5OTZ_X*_?\%>/ _\ P2+^&7A;X@^,/@7XD\>3>+]2NK'3-/\
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M;[]M[X:1^-Y+\6(T ^++<R"[+;1;,X;RUG+?+Y18/N.W;GBO?J_ES_X.>?\
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M_'$-1U@K^\U.YC&4/<1+R(Q[\L>YQQ7>65E9Z;:1V&G6D4$$2A8H88PB(/0
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MPA1G1HU< I_197\TW_!3G_E<5^'G_96_AE_Z+TNOZ6: "BBB@ HHHH ****
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MHLOWHYH,\H*^2_"7[%7_  >3_L7Z1_PJ#X ?M(67C?PY:)Y-A?/XKT/5DBB
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M."K#V(JG\0/B!X(^%/@?5OB7\2O%=AH7A_0=/EOM9UG5+E8;>SMHE+R2R.Q
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>Y:UXAG_ &R?@SX=N7D_LFU^&5S<V2DG8+B7495G(]]D-OGZ"@#T[X#>,O\
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M6%SI-Y\*-9\2^,O!6D6ZW4%U96J71GM(X[IMLHDB@9=LK;27P2!7X>?M'_\
M!0G_ (-@O"?A/5/BG^Q=_P $J]=UGXLW]M*WAVT\:I<1^'M+O7!"2W-BVISV
MLJQL0XMX[=HWV[-R Y !J?\ !F/X_P!=\,_\%-_B9\)/#.L37/AG7/A3>W=U
M&"0DTEGJEDMK<LO'*I<SJ..//->D_P#!,S]I#X&_\$U/^#BO]L"__P""@WQ
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M &-X*\+Z?H.D>>07^RV=M';Q;L<9V1KGWKJ** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH K:QH^D>(=)N=!U_2[:^
ML;V!X+RRO(%EBGB8%61T8$,I!(((((-<3_PR?^RS_P!&U?#_ /\ "-L?_C5=
M_10!QWAG]GCX >"M<@\3^#?@;X.TC4K4L;74=,\,VEO/"64J=LB1AERK$'!Y
M!([U+XN^ OP,^(&M-XD\>?!CPGK>HO&J/?ZOX=MKF9E7A5+R(6('89XKK**
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M#(+:- Y&>,YKLZ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
DB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>esg251022.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 esg251022.jpg
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M\W&XML/HG*QOE 0GZ3!H:6EI:6EI:6G=79D#LW#L8H'<,8]&8__@-*RLF:B
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M+ENW \QICL<0.W()XF>L1]R4-4A>ZHC"3".<*5\: (\?^F&7!9I_2L!<6%B
MO((<%!!>%2#GHRA?L+@@3]"8KQCG^CP4%A2*%<A^S&\Y<ERV MW;AS8!\OPL
MY.=8GWH5R!J^GIKGE.\J-"^W%1%!/E>,9R[,SY=[D0_E7.<=!V;+=T?$1J'5
MV"YXI?OGJ#VS'7KV[XW^_^N X<T&8%CW01@Z9@A&K9V P:M'H=_2X>BQ8#"Z
MS.B!P?.^QZB%S=!B;&-\->QK=)[7"1XA=_[I1E5[F)/B,^ C$!H1FHA1/VS'
MIN6N6#'[.,;V=42P?SP"_>(0'YN&\P*W'1LLQQ7W,(0$Q"-<H#HB- F=&JS
MF2-^2$G*Q)859S%"H/N0\U5T:[I*@3>/34TQZL,^K==CZ\IS2)#OC(M)$[BU
MYC,@/34;(8$)&-?/$5.&[49X2"+.'/5#YX8K<.E<B#K7Q$'.F#5ZG^6(TM+
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M7T%!PHT=&:LJ LSE:>/>PRH<PT. V3<D3,V"X1,<AE !9G:J;D=S-V['GP2
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MEFLBXZA \]$&R/=?A"*/SB@Z)[!\OJD!S>[?"OP*+(>M )*DDHO>AZ*0]4#
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M\V^,P'+$ >1>G2NP3!-@]IB*@KBR'Y7?#[I=8+:&F.QT.HA7GJV/%_Y=WS(
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M(7 [& !O>JWE>ZWG\O9EOC>_OELQ#<SFIH'9W#0PFYL&YK)- [.Y:6"N8M/
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MG:K6^_O[JW3JTJ6+:EQ883/-.G;LJ(ZY4[J?@#DI*0G-FC6#HZ.C9<V]U<V
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MYG,IU]#JREA5GMJR3$FE?36C:N-ZF1^J5Z^NTN2SSSY3C2L]9,QCK.ONE<R
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MD%N8/O1 6YU;_)U8Q[S[[KLJGS -.4: Y8U<PR<3Y$T^Q2%S<O_[03<%9O[
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M?&:$K+/OL<<>9;"R^>:;KRR'8*<,ZE(]>@_@ ;,.(8@YWE9;;54<)8B=C+J
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MTV9D"J5"2)#B>%0")^(B[-N^]<^1JA1&*GOBN)R>XPAN@I.+=*[94#]@CD$
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MU?>[^FNO7PBYOD%]O-\VCCNHK;K4!<S#R#EKU]-/KD&=A3\/ 52#@B[?4Q-
M-Y@R:(@VF"[U ^9>L1VV0>XR&%#7[$E]::NY+-?0#Y@!GT270>.@.\$&O,/R
MS%S0J, \6](GAXF)DC<&YW&7W'[8S=TY?@0#2)K%^ZG$V8' + /I5I0@I]/K
M:$;=$21\'@'7R%76HET0V[4;R<5X+T,J2V3_MJ.UKVTBZ.O 8;2<6.^4 4$Q
MG%'[.\=Q[%['-Q5U ?.XB'-@ #(((74Z'=?>3P++L,!<4^]^J[N\TRWEKUU[
M%S#7MIUJW:UNN89^@XRIJ@N85X? DGYAT-^6.A\&0&=27<"\)FHR_7P48)Y.
M\;&3[0_\L;L577U\E+X_&6!N"U!V#:C7!/4#9MPAV>>NF[L'85?\47O0JVZU
MM6D*VH_:3$+V"<Z)=O0_7F,69:%>9@DY1@QP]0GGC;Z!:]K7P%_%8,9WDQT(
M4A<P.U;;)SM^E,/U.*_ZB-<AW.7:XIK58>^U>A]\UN[WO>WC^,%Y[7HDOM&T
M*7?N>GU'G$_=N;ON;E,<VUTWGQFX2OKB.'<&9<K-#'#W;+(:",RR,!X8BWDC
M"NB6DHIS:]O<2[<,C=P4SJUOMS;=#D7R]G&;T!PAMRD9J]MZ]OW;O_W;<JLN
M@I=MW!9RBP^HFX^BHMQ2,S+PWXC=;5#'=TO.\1B"6XI>NY7F]I=;CS'Y>U0-
M"\QN&W=EY&9*##_F.[H%.*@\',ADIV*$)@/,;M6Z_:G=8HZQ]FG#C"D&#+Z?
M=!BVUCOR=QN6 W-\M[%E$**CKBZYY5K+4G0!L]O=IA2$S)>M3=W1D=75L-)'
MW4X>5@)%O[K1GJ9VM)WC=&DF@7DNJ1\P:UOVI,T$>O9MOG0\(V"5%9^!R]D0
M'S[HSE:(3?'O@M\PFBPP.[ZZ)-DFL6%<!$1,P2*^CN^<JJ8*S&NZNH Y$G08
MA=_6C\1T_<A=*)\!/E,",8O^9"H2WA%+,(PV\_ ^=G%'UY0G=Z[8/^$/S!)3
M+<TC-[W/5"AW&0)RQ06\@F< G/ZM3_"YIE^*E1C*=![G=WS3:I1)_% ^YQJV
M#X5JP&Q0Y[RX2US%3Z:P*9N^A.],73.E33VI0U/4,(:'6#&/S[$ ,'4=KDG9
M)%J#YPP\3/41&]WA$/M"ZM0Y'5L\=0? ?'#Q/)Z?^9N_^9L"NC%(49?:"F^:
MAF6JZ3_\PS^L,H5*6U@$0%OK>VWQ#9.M/QH(S$XJ<^Q"5:R'!U2FBXHGVQF(
MSU6@!G"QYEJJ3(:A0C6RN57F=^GH#-B<N[9<]+R)I_I=C/F3SB^ ,SR5IR-H
M0!/WX^$XKTU'4#$^<PX5J4RU=7DGJQHPJP_.W$-4X?B40>."-])(.I1@1XR?
M08!"(.MS0,^8'"<:5?WH& %!C-'[ &$.(1[J4#;P:*1JOB[C\40Z,#%?CQ,0
M:&/NI\YJ_IRZ47?JM 9MPZ@&S!Q6!&ZVX#O7)^BI0T;N(1QE83><@ Y(Z@ T
MN&[E9P>]8.?A1@_[!"R03F))-0\;<0HZI//TSC_VO?:(H*4MO-?Y=$1U% ,,
M95;'!FKJS'=&K"18V<^#1M&V;74!LP&"/L AJB<.*O8W[];U*R-G8HZA<X;]
M:F/OXRZ"<BF#P:%!)<?6!BX#$6VC'I7;MG$MUFGEU-B&NG;<@%C'X#3-\>UU
M,M.A!.:ZNH!9&_&)'MID5_HM.!7 9$WX1\%37^FM5S;3MG=^)_R&MN5GV!R;
M8I.136.#M@L_Q@;=[M1GXST?I"SZ-Q\&VJGMFV2-'%^?C,P0N^>7G-]Y]/U^
MX%<#9C% 747_9%/. P;\-V?8M;IVVRFO]\H;BOYF_[;X!/W!P)M @_?:1YDE
M<ER/ZW#=KI>421O$ Y&.J\ZB3LG#1I;.4EX 9GZ\,@7<&?@JDV,/4A<PJV=M
M&0,%Y59^G_-S?(YZD;3@>V+ #UI<2YR?/[1=V !;BCKC]_F-\ _:T6?C(&5W
M';W C ?$3W/,@1<NP1L80S]BV]H"I)+K,VV+[>$4<<@^V ;WB/-BD&=M<!%)
MX#FWYYC8HF/*9.JOEA0,6U-O %CB3_\5 P$UL1?@R$][ID1L YV@G2R1:#_]
MW_>340V8)2_C(3BV(B:S$\]C82[7Q#_83EG8@P& _N0[_=_@0&P79R1%^2JQ
MQT(#?!;V4_>.H4^HX[:OTQZN3Y^S+7[S&=^G#=BI_VVY%MLZOMCG&FS3;G=M
MQK]H,T >L(TA_$U% X%9)]& Q+AD(UV,_T"85#((8U@ZCNR8S*4+\?"'!N9(
M=-)H;/][@5FG=%SGB?5- 2$YGL_(<>T?#WJ <R,)'0!L,#I.62=1^:.J!LP<
M*3!5%U9V8" :!11I.!V3D2B/[SEWY6?PC(K#5#[78#1I] JF@"]@48>@2>>2
M*?80&!#DQ(R&U;V.Z/PRDCJV@01#V&BCC8IA*@M'*+.I'7S'60>0Z?3N%CCN
M5%0#9FVHO#H?Q\&I.S>#!N9 5AUP3@88MF4_MM.AE(^#4#_^MY>!(AU"?7)&
M@H!K4)]&KYP/"=0>0'*\D,"KOCE']2;8S7L;1(R*=3YUJB[9' @U2%0VG=6@
M@OVQ2V  4  G)]AK%]0%S!R-:_9?.00R;:+ME$W=L"'M;SDN\PUC],X^M!5G
MS;9L;SOM;(ZNOA300MK7Y_H!FW$>=B9 @F$C;/7EN!R*\PBFCBLP@ XV/MU*
M8*ZK!LSJ2=!B)^%K0]H-'$A>:&>^0_N%M)V HN\+1FQ>GQ+<'4_P8^/ZICN$
MMM,/[1</+O-C[$<?YV\-S/0[-L+7^-./V:7C"Z*.9U\^1I]D2_I]W$GBWV3G
MV)YEH03F.&Y--6"63&'#^K>^(%'"/ZH#R1.VZS/^3YD<7UWH6_HZZ%47MG?;
M/22@\C?Z@_G[H$F]*R/_%8-],<HU\Q5\ M_.C[A>OI0_MK\Z4W_A'_5!/D,9
MU;4^RO^+7P8U_(UV<"V#5 -FYP%>KE7[BKG.PT:45RS_P <^4+91?_Z#'G6L
M+MB1ZU4&/M UJS,^1ANR%WY#FVIW;:W.^.,88,RVNH"9[U-G!A/LT[6[+OU.
MF_.?VIVO)]#H,[9O7_*]>A37^5[?JV=U1WP[OZ_.Q2:VI[WU/VT?R0]EXP?%
M+G;(KB(&LVTP3?J0NM9^P$_[BNUBD?/78D\_U8!9&[)'TN;LEM0/7G$M&(1-
MR,8[AA@D?K)_DD%6'OX _/,?,N7L@MBX>I30TS>5ORTV9["ISO4G23_<II[T
M777:?FB;V#8_0CC!,9VO'7-Q0$@;JEL^E4W'8&^R&@C,G+ 3D(H1?($%*%79
M@KI?6A&(-;Z"*+S.ID'MH]$9IXI@=#HT0W6!LH!Q82J-<](0*L1H%JS[C'/0
M4/X<PV@-.#-,AJCR?,[(.#3.5$4Z[ZBJ ;.*#\/FG-4)PU 6[W4"P4? <PTZ
M&B-D4*0.&%_ FD"BGAF-(*#.@*4ZX%A#SJE.09=KCE&; *3>&)?OB2$ZEGH*
M&;5I&_5H.X:IXTY%-6 F,,DV&+]Z ?_:TW^#F@@(C)BC!;P<CVO1T0 I>]+F
MT2G:4D^<EGW777?=8A\"@*!% H.@WAX("'[L4QF4F=/DT(B-1^<&VMI)G7,N
M]F/?VD^P="Z!D8R4E;=77<"LO@538"28<Z0"D>OF$/6#&/2$XP8X!J,<KS(8
M& K$MM-V^H']>^=C^5Y?)9D0URTC+IAH%VVG362\'(>3<YRXV\!1N?;I5@)S
M735@=NO7LFQLE9W'@)"? UDD:&M'MJP_\8?D/1\1TA]D,+4[W\-O:VMM'/[%
M?]E"Q]%&P)*M\W]LA/VS/7:O+&S?[6*V)>CRMX[-MOWQ86 "D$36%&#IWR 8
MK)$8T+MR3:@&S,ICWX B_EZ_9+/LV_$)@ ([$"!>\:7Z-_^C?PJ@T>])1DH,
M<CW@$%RYII"Z"/_-I_*E0)\O57[G]3W?9+ 1D!I27\I$0(1_$U?"1_+MZD)?
MY$/ZJ0;,/N/C8E]MH[W(^<1&924^5%NP _ 3TQ3(M;G3YEH<SW%<'Q]M'[;D
M/Q\/JOC+<5$7, .Z>?/FE3IV/:[%]8H9^A/?'%-"U85KYT/U SPCMK)[_=0U
M:UOQ5>QP7%#+9MBJ^A/[Q0_'<GSGT3XDJ80/M+D!B&-H'_4I#HA;^J+C\ GZ
MD#Y.8K?W8FS<'1A6-6!FGVR5CV'+RJ0.Q!V99>52!]J8_:A;-LSVK.VO_.Q7
MW8%:=:MO\O.QW*)^H;^1&0#M@3WI+WR.[<4Q_9M?4^>FT.BGRB@^Q9QO?<]Q
MM8G/G=\^[9CK>L4Z7,87D;:+/CP5#01FAJ>!B1$(ZOZ3QF,L.A5';#L.6V>*
M"]/@ C9#9C :R+:D(516='#;<.KM>;=&WCXC,!Z5#=*<+V!-F1Q;Y2JS;)M*
MG YU 3-GZWR,1/#1J$91LH<<N(;4,72L&+'IJ*0A.7-0H[."/YW9>00FG^N
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M#8T$S*M#1K)&QIPW1ST5<8R<^'2I!LP""8B:+0,8Y%!G0EW /(S&H?RK2UW
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M2]&F/K.]U7?8E'.R!_:L7<.?L"T^W-KFMI=Y8P/V8=>D/X9/6IVJ ;-S\Z=
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M]"G!5]WI;WQ'#'[U$6!@7]>@'QL$JT-]@(_B6_@% 5I]Z<ND?=2C<PK4;-B
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MT>^ @7IDIYP:AZ).#?!\[PZ&,OFOC6QC>XY3UMU^CL^^_;A#9#^FH@3FNFK
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M70G,=24PU]4%S&(5UN!_/!_2"\LD"=@&2M,UXCBRS@'(LL[F,,\U)3"/KH'
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MS'4E,->5P%Q7 G.W$IA'UTC O+8H@;FN!.:Z$IB[E<!<5P)S70G,=24PUY7
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=E4JE4IUJFO\/F!:11JCR*<8     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image.jpg
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J=PU<#\/^4J5*E2I5JE2I4J7FMIS['Q-1/-?G =S"     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
